0001670541 2022 Q1 FALSE--09-30 http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2021-01-31#PensionPlansDefinedBenefitMember 0001670541 2021-10-01 2021-12-31 0001670541 2021-12-31 xbrli:shares iso4217:USD 0001670541 2020-10-01 2020-12-31 iso4217:USD xbrli:shares 0001670541 2021-09-30 0001670541 2020-09-30 0001670541 2020-12-31 adnt:entity 0001670541 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-12-31 0001670541 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-09-30 0001670541 adnt:YFASMember adnt:YanfengMember 2021-03-12 xbrli:pure 0001670541 adnt:AdientMember adnt:YFASMember 2021-03-12 2021-03-12 0001670541 adnt:AYMMember adnt:YanfengMember 2021-03-12 0001670541 adnt:AdientMember adnt:AYMMember 2021-03-12 0001670541 adnt:YFASMember adnt:YFASMember 2021-03-12 2021-03-12 0001670541 adnt:YFASMember 2021-03-12 2021-03-12 iso4217:CNY 0001670541 adnt:YFASMember 2021-09-30 2021-09-30 0001670541 adnt:YFASMember 2021-12-31 2021-12-31 0001670541 adnt:YFMMember adnt:YFASMember 2021-03-12 0001670541 adnt:YFMMember 2021-03-12 2021-03-12 0001670541 adnt:YFATMember adnt:YFASMember 2021-03-12 2021-03-12 0001670541 adnt:YFATMember 2021-03-12 2021-03-12 0001670541 adnt:YanfengMember 2021-03-12 2021-03-12 0001670541 adnt:YanfengMember adnt:YFASMember 2021-03-12 2021-03-12 0001670541 adnt:YFASMember 2021-03-12 2021-03-12 0001670541 adnt:YFASMember 2021-04-01 2021-06-30 0001670541 adnt:YFASMember 2021-09-30 2021-09-30 0001670541 adnt:TheBoxunAgreementMember adnt:BoxunMember adnt:CQYFASMember 2021-03-12 2021-03-12 0001670541 adnt:TheBoxunAgreementMember adnt:CQYFASMember 2021-03-12 2021-03-12 0001670541 adnt:TheBoxunAgreementMember adnt:CQADNTMember 2021-03-12 2021-03-12 0001670541 adnt:TheBoxunAgreementMember adnt:CQADNTMember 2021-12-31 2021-12-31 0001670541 us-gaap:SubsequentEventMember adnt:TheBoxunAgreementMember adnt:CQADNTMember 2022-01-01 2022-01-31 0001670541 srt:ScenarioForecastMember adnt:TheBoxunAgreementMember adnt:CQADNTMember 2022-02-01 2022-03-31 0001670541 adnt:TheBoxunAgreementMember adnt:CQADNTMember 2021-12-31 0001670541 adnt:YFASMember adnt:CQYFASMember 2021-03-12 2021-03-12 0001670541 adnt:AdientMember adnt:CQYFASMember 2021-03-12 2021-03-12 0001670541 adnt:YFATMember adnt:AdientMember adnt:KEIPERSeatingMechanismsCoLtdMember 2021-03-12 2021-03-12 0001670541 adnt:YFATMember adnt:KEIPERSeatingMechanismsCoLtdMember 2021-03-12 2021-03-12 0001670541 adnt:YFASMember adnt:GZDFASMember adnt:AdientMember 2021-03-12 2021-03-12 0001670541 adnt:YFASMember adnt:GZDFASMember 2021-03-12 2021-03-12 0001670541 adnt:YFASMember adnt:YHASMember adnt:AdientMember 2021-03-12 2021-03-12 0001670541 adnt:YFASMember adnt:YHASMember 2021-03-12 2021-03-12 0001670541 adnt:YFASMember 2021-11-01 2021-11-30 0001670541 adnt:YanfengMember adnt:YFAIMember 2021-10-01 2021-12-31 0001670541 adnt:AdientMember adnt:YFAIMember 2021-10-01 2021-12-31 0001670541 adnt:CQYFASMember 2021-09-30 2021-09-30 0001670541 adnt:CQADNTMember 2021-09-30 0001670541 adnt:LFADNTMember 2021-09-30 0001670541 adnt:CQADNTMember 2021-09-30 2021-09-30 0001670541 adnt:LFADNTMember 2021-09-30 2021-09-30 0001670541 adnt:CustomerRelationshipsAndPatentedTechnologiesMember srt:MinimumMember 2021-09-30 2021-09-30 0001670541 srt:MaximumMember adnt:CustomerRelationshipsAndPatentedTechnologiesMember 2021-09-30 2021-09-30 0001670541 adnt:MeasurementInputRateOfReturnMember 2021-09-30 0001670541 adnt:CustomerRelationshipsAndPatentedTechnologiesMember 2021-09-30 2021-09-30 0001670541 adnt:ShenyangJinbeiAdientAutomativeComponentsCoLtdMember 2021-03-31 2021-03-31 0001670541 adnt:ShenyangJinbeiAdientAutomativeComponentsCoLtdMember 2021-03-31 2021-03-31 0001670541 adnt:ShenyangJinbeiAdientAutomativeComponentsCoLtdMember 2021-01-01 2021-03-31 0001670541 adnt:ShenyangJinbeiAdientAutomativeComponentsCoLtdMember 2021-04-01 2021-04-01 0001670541 adnt:EntitiesInChinaAndPropertiesInUSMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2021-10-01 2021-12-31 0001670541 adnt:FranceAndTurkeyMember 2021-09-30 0001670541 adnt:FranceAndTurkeyMember 2020-10-01 2021-09-30 0001670541 country:TR 2021-10-01 2021-12-31 0001670541 country:TR 2021-10-01 2021-10-31 0001670541 adnt:AmericasSegmentMember 2021-09-30 0001670541 adnt:EMEASegmentMember 2021-09-30 0001670541 adnt:AsiaSegmentMember 2021-09-30 0001670541 adnt:AmericasSegmentMember 2021-10-01 2021-12-31 0001670541 adnt:EMEASegmentMember 2021-10-01 2021-12-31 0001670541 adnt:AsiaSegmentMember 2021-10-01 2021-12-31 0001670541 adnt:AmericasSegmentMember 2021-12-31 0001670541 adnt:EMEASegmentMember 2021-12-31 0001670541 adnt:AsiaSegmentMember 2021-12-31 0001670541 us-gaap:PatentsMember 2021-12-31 0001670541 us-gaap:PatentsMember 2021-09-30 0001670541 us-gaap:CustomerRelationshipsMember 2021-12-31 0001670541 us-gaap:CustomerRelationshipsMember 2021-09-30 0001670541 us-gaap:TrademarksMember 2021-12-31 0001670541 us-gaap:TrademarksMember 2021-09-30 0001670541 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0001670541 us-gaap:OtherIntangibleAssetsMember 2021-09-30 0001670541 us-gaap:LondonInterbankOfferedRateLIBORMember adnt:TermLoanBLIBORPlus350DueIn2028Member 2021-12-31 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member 2021-12-31 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member 2021-09-30 0001670541 us-gaap:UnsecuredDebtMember adnt:NotesDue2026Member 2021-12-31 0001670541 us-gaap:UnsecuredDebtMember adnt:NotesDue2026Member 2021-09-30 0001670541 us-gaap:UnsecuredDebtMember adnt:NotesDue2024Member 2021-12-31 0001670541 us-gaap:UnsecuredDebtMember adnt:NotesDue2024Member 2021-09-30 0001670541 us-gaap:UnsecuredDebtMember adnt:SeniorNotesDue2025900Member 2021-12-31 0001670541 us-gaap:UnsecuredDebtMember adnt:SeniorNotesDue2025900Member 2021-09-30 0001670541 us-gaap:UnsecuredDebtMember adnt:EuropeanInvestmentBankLoanduein2022Member us-gaap:EurodollarMember 2021-10-01 2021-12-31 0001670541 us-gaap:UnsecuredDebtMember adnt:EuropeanInvestmentBankLoanduein2022Member 2021-12-31 0001670541 us-gaap:UnsecuredDebtMember adnt:EuropeanInvestmentBankLoanduein2022Member 2021-09-30 0001670541 us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001670541 adnt:NorthAmericanSubfacilityMember us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001670541 adnt:EuropeanSubfacilityMember us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001670541 us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2021-10-01 2021-12-31 0001670541 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2021-10-01 2021-12-31 0001670541 us-gaap:LineOfCreditMember 2021-12-31 0001670541 us-gaap:RevolvingCreditFacilityMember 2021-10-01 2021-12-31 0001670541 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember srt:MinimumMember 2021-10-01 2021-12-31 0001670541 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2021-10-01 2021-12-31 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member us-gaap:SecuredDebtMember 2021-10-01 2021-12-31 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member us-gaap:SecuredDebtMember 2021-12-31 0001670541 adnt:IncrementalTermLoanMember us-gaap:SecuredDebtMember 2021-12-31 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member 2021-10-01 2021-12-31 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member us-gaap:EurodollarMember us-gaap:SecuredDebtMember 2021-04-01 2021-04-30 0001670541 us-gaap:BaseRateMember adnt:TermLoanBLIBORPlus350DueIn2028Member us-gaap:SecuredDebtMember 2021-04-01 2021-04-30 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member us-gaap:SecuredDebtMember 2021-04-01 2021-04-30 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member us-gaap:SecuredDebtMember 2021-04-30 0001670541 2021-04-30 0001670541 adnt:NotesDueIn2026Member us-gaap:SeniorNotesMember 2021-12-31 0001670541 adnt:NotesDueIn2026Member us-gaap:SeniorNotesMember 2021-03-31 0001670541 adnt:NotesDueIn2026Member us-gaap:SeniorNotesMember 2021-01-01 2021-03-31 0001670541 adnt:NotesDueIn2026Member us-gaap:SeniorNotesMember 2021-06-30 0001670541 adnt:NotesDueIn2026Member us-gaap:SeniorNotesMember 2020-10-01 2021-06-30 0001670541 adnt:TermLoanBLIBORPlus350DueIn2028Member us-gaap:SecuredDebtMember 2021-06-30 0001670541 us-gaap:UnsecuredDebtMember adnt:NotesDue2026Member 2020-07-01 2020-09-30 0001670541 us-gaap:UnsecuredDebtMember adnt:NotesDue2026Member 2020-09-30 0001670541 us-gaap:UnsecuredDebtMember adnt:NotesDue2026Member 2020-10-01 2021-09-30 iso4217:EUR 0001670541 us-gaap:SubsequentEventMember us-gaap:UnsecuredDebtMember adnt:NotesDue2024Member 2022-01-31 0001670541 us-gaap:EurodollarMember 2021-10-01 2021-12-31 0001670541 us-gaap:UnsecuredDebtMember 2021-10-01 2021-12-31 0001670541 us-gaap:UnsecuredDebtMember adnt:EuropeanInvestmentBankLoanduein2022Member 2020-10-01 2020-12-31 0001670541 us-gaap:UnsecuredDebtMember adnt:EuropeanInvestmentBankLoanduein2022Member 2021-05-01 2021-05-31 0001670541 adnt:SeniorNotesDue2025900Member us-gaap:SeniorNotesMember 2020-04-20 0001670541 adnt:SeniorNotesDue2025900Member us-gaap:SeniorNotesMember 2020-04-20 2020-04-20 0001670541 adnt:NotesDue2024Member us-gaap:SeniorNotesMember 2020-04-20 0001670541 adnt:NotesDue2024Member us-gaap:SeniorNotesMember 2020-04-20 2020-04-20 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001670541 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember country:JP 2021-12-31 adnt:instrument 0001670541 us-gaap:InterestRateCapMember 2021-12-31 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-12-31 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-09-30 0001670541 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-12-31 0001670541 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-09-30 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentAssetsMember 2021-09-30 0001670541 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001670541 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentAssetsMember 2021-09-30 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember 2021-09-30 0001670541 us-gaap:NondesignatedMember 2021-12-31 0001670541 us-gaap:NondesignatedMember 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2021-09-30 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-09-30 0001670541 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001670541 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-09-30 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongTermDebtMember 2021-12-31 0001670541 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongTermDebtMember 2021-09-30 0001670541 us-gaap:LongTermDebtMember us-gaap:NondesignatedMember 2021-12-31 0001670541 us-gaap:LongTermDebtMember us-gaap:NondesignatedMember 2021-09-30 0001670541 us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeContractMember 2021-10-01 2021-12-31 0001670541 us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeContractMember 2020-10-01 2020-12-31 0001670541 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:ForeignExchangeContractMember 2021-10-01 2021-12-31 0001670541 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember us-gaap:ForeignExchangeContractMember 2020-10-01 2020-12-31 0001670541 us-gaap:CostOfSalesMember us-gaap:ForeignExchangeContractMember 2021-10-01 2021-12-31 0001670541 us-gaap:CostOfSalesMember us-gaap:ForeignExchangeContractMember 2020-10-01 2020-12-31 0001670541 us-gaap:InterestExpenseMember us-gaap:ForeignExchangeContractMember 2021-10-01 2021-12-31 0001670541 us-gaap:InterestExpenseMember us-gaap:ForeignExchangeContractMember 2020-10-01 2020-12-31 0001670541 us-gaap:NetInvestmentHedgingMember us-gaap:ForeignExchangeContractMember 2021-10-01 2021-12-31 0001670541 us-gaap:NetInvestmentHedgingMember us-gaap:ForeignExchangeContractMember 2020-10-01 2020-12-31 0001670541 us-gaap:CashFlowHedgingMember 2021-10-01 2021-12-31 0001670541 us-gaap:CashFlowHedgingMember 2020-10-01 2020-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-12-31 0001670541 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentAssetsMember 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:OtherCurrentAssetsMember 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001670541 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001670541 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001670541 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001670541 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember 2021-12-31 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001670541 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-09-30 0001670541 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:OtherCurrentAssetsMember 2021-09-30 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentAssetsMember 2021-09-30 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:OtherCurrentAssetsMember 2021-09-30 0001670541 us-gaap:InterestRateCapMember us-gaap:OtherNoncurrentAssetsMember 2021-09-30 0001670541 us-gaap:InterestRateCapMember us-gaap:FairValueInputsLevel1Member us-gaap:OtherNoncurrentAssetsMember 2021-09-30 0001670541 us-gaap:InterestRateCapMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherNoncurrentAssetsMember 2021-09-30 0001670541 us-gaap:InterestRateCapMember us-gaap:OtherNoncurrentAssetsMember us-gaap:FairValueInputsLevel3Member 2021-09-30 0001670541 us-gaap:FairValueInputsLevel1Member 2021-09-30 0001670541 us-gaap:FairValueInputsLevel2Member 2021-09-30 0001670541 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel1Member 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel2Member 2021-09-30 0001670541 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:FairValueInputsLevel3Member 2021-09-30 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-09-30 0001670541 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-09-30 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherNoncurrentLiabilitiesMember 2021-09-30 0001670541 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:OtherNoncurrentLiabilitiesMember 2021-09-30 0001670541 us-gaap:CommonStockMember 2021-09-30 0001670541 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001670541 us-gaap:RetainedEarningsMember 2021-09-30 0001670541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001670541 us-gaap:ParentMember 2021-09-30 0001670541 us-gaap:NoncontrollingInterestMember 2021-09-30 0001670541 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001670541 us-gaap:ParentMember 2021-10-01 2021-12-31 0001670541 us-gaap:NoncontrollingInterestMember 2021-10-01 2021-12-31 0001670541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2021-12-31 0001670541 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001670541 us-gaap:CommonStockMember 2021-12-31 0001670541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001670541 us-gaap:RetainedEarningsMember 2021-12-31 0001670541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001670541 us-gaap:ParentMember 2021-12-31 0001670541 us-gaap:NoncontrollingInterestMember 2021-12-31 0001670541 us-gaap:CommonStockMember 2020-09-30 0001670541 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001670541 us-gaap:RetainedEarningsMember 2020-09-30 0001670541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001670541 us-gaap:ParentMember 2020-09-30 0001670541 us-gaap:NoncontrollingInterestMember 2020-09-30 0001670541 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001670541 us-gaap:ParentMember 2020-10-01 2020-12-31 0001670541 us-gaap:NoncontrollingInterestMember 2020-10-01 2020-12-31 0001670541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-01 2020-12-31 0001670541 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001670541 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-09-30 0001670541 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:ParentMember 2020-09-30 0001670541 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-09-30 0001670541 us-gaap:CommonStockMember 2020-12-31 0001670541 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001670541 us-gaap:RetainedEarningsMember 2020-12-31 0001670541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001670541 us-gaap:ParentMember 2020-12-31 0001670541 us-gaap:NoncontrollingInterestMember 2020-12-31 0001670541 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0001670541 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0001670541 us-gaap:AccumulatedTranslationAdjustmentMember 2021-10-01 2021-12-31 0001670541 us-gaap:AccumulatedTranslationAdjustmentMember 2020-10-01 2020-12-31 0001670541 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001670541 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001670541 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-09-30 0001670541 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-09-30 0001670541 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-10-01 2021-12-31 0001670541 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-10-01 2020-12-31 0001670541 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0001670541 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001670541 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-09-30 0001670541 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0001670541 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001670541 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001670541 adnt:RedeemableNoncontrollingInterestMember 2021-09-30 0001670541 adnt:RedeemableNoncontrollingInterestMember 2020-09-30 0001670541 adnt:RedeemableNoncontrollingInterestMember 2021-10-01 2021-12-31 0001670541 adnt:RedeemableNoncontrollingInterestMember 2020-10-01 2020-12-31 0001670541 adnt:RedeemableNoncontrollingInterestMember 2021-12-31 0001670541 adnt:RedeemableNoncontrollingInterestMember 2020-12-31 0001670541 adnt:A2022RestructuringPlanMember 2021-12-31 0001670541 adnt:A2022RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2022RestructuringPlanMember 2021-09-30 0001670541 adnt:A2022RestructuringPlanMember 2021-09-30 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2022RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2022RestructuringPlanMember 2021-12-31 0001670541 adnt:A2021RestructuringPlanMember 2021-09-30 0001670541 adnt:A2021RestructuringPlanMember 2020-10-01 2021-09-30 0001670541 adnt:A2021RestructuringPlanMember adnt:EMEASegmentMember 2021-09-30 0001670541 adnt:A2021RestructuringPlanMember adnt:AmericasSegmentMember 2021-09-30 0001670541 adnt:A2021RestructuringPlanMember adnt:AsiaSegmentMember 2021-09-30 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2021RestructuringPlanMember 2021-09-30 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2021RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 adnt:A2021RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2021RestructuringPlanMember 2021-12-31 0001670541 adnt:A2021RestructuringPlanMember 2021-12-31 0001670541 adnt:A2020RestructuringPlanMember 2019-10-01 2020-09-30 0001670541 adnt:A2020RestructuringPlanMember adnt:AmericasSegmentMember 2019-10-01 2020-09-30 0001670541 adnt:A2020RestructuringPlanMember adnt:EMEASegmentMember 2019-10-01 2020-09-30 0001670541 adnt:A2020RestructuringPlanMember adnt:AsiaSegmentMember 2019-10-01 2020-09-30 0001670541 2019-10-01 2020-09-30 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2020RestructuringPlanMember 2021-09-30 0001670541 adnt:A2020RestructuringPlanMember us-gaap:ForeignCurrencyGainLossMember 2021-09-30 0001670541 adnt:A2020RestructuringPlanMember 2021-09-30 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2020RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 adnt:A2020RestructuringPlanMember us-gaap:ForeignCurrencyGainLossMember 2021-10-01 2021-12-31 0001670541 adnt:A2020RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2020RestructuringPlanMember 2021-12-31 0001670541 adnt:A2020RestructuringPlanMember us-gaap:ForeignCurrencyGainLossMember 2021-12-31 0001670541 adnt:A2020RestructuringPlanMember 2021-12-31 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2019RestructuringPlanMember 2021-09-30 0001670541 us-gaap:ForeignCurrencyGainLossMember adnt:A2019RestructuringPlanMember 2021-09-30 0001670541 adnt:A2019RestructuringPlanMember 2021-09-30 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2019RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 us-gaap:ForeignCurrencyGainLossMember adnt:A2019RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 adnt:A2019RestructuringPlanMember 2021-10-01 2021-12-31 0001670541 us-gaap:EmployeeSeveranceMember adnt:A2019RestructuringPlanMember 2021-12-31 0001670541 us-gaap:ForeignCurrencyGainLossMember adnt:A2019RestructuringPlanMember 2021-12-31 0001670541 adnt:A2019RestructuringPlanMember 2021-12-31 0001670541 adnt:RestructuringPlan201820172016Member 2021-10-01 2021-12-31 0001670541 adnt:RestructuringPlan2018Member 2021-12-31 0001670541 adnt:RestructuringPlan2017Member 2021-12-31 0001670541 adnt:RestructuringPlan2016Member 2021-12-31 adnt:employee 0001670541 2021-12-31 2021-12-31 adnt:plant 0001670541 us-gaap:SecretariatOfTheFederalRevenueBureauOfBrazilMember us-gaap:ForeignCountryMember 2021-10-01 2021-12-31 0001670541 us-gaap:SecretariatOfTheFederalRevenueBureauOfBrazilMember us-gaap:ForeignCountryMember 2020-10-01 2020-12-31 adnt:segment 0001670541 adnt:AmericasSegmentMember us-gaap:OperatingSegmentsMember 2021-10-01 2021-12-31 0001670541 adnt:AmericasSegmentMember us-gaap:OperatingSegmentsMember 2020-10-01 2020-12-31 0001670541 us-gaap:OperatingSegmentsMember adnt:EMEASegmentMember 2021-10-01 2021-12-31 0001670541 us-gaap:OperatingSegmentsMember adnt:EMEASegmentMember 2020-10-01 2020-12-31 0001670541 us-gaap:OperatingSegmentsMember adnt:AsiaSegmentMember 2021-10-01 2021-12-31 0001670541 us-gaap:OperatingSegmentsMember adnt:AsiaSegmentMember 2020-10-01 2020-12-31 0001670541 us-gaap:IntersegmentEliminationMember 2021-10-01 2021-12-31 0001670541 us-gaap:IntersegmentEliminationMember 2020-10-01 2020-12-31 0001670541 us-gaap:CorporateNonSegmentMember 2021-10-01 2021-12-31 0001670541 us-gaap:CorporateNonSegmentMember 2020-10-01 2020-12-31 0001670541 adnt:EMEASegmentMember 2020-10-01 2020-12-31 0001670541 country:BR 2020-10-01 2020-12-31 0001670541 adnt:YFASMember 2020-10-01 2020-12-31 0001670541 country:US 2021-10-01 2021-12-31 0001670541 country:US 2020-10-01 2020-12-31 0001670541 country:MX 2021-10-01 2021-12-31 0001670541 country:MX 2020-10-01 2020-12-31 0001670541 adnt:OtherNonUSMember 2021-10-01 2021-12-31 0001670541 adnt:OtherNonUSMember 2020-10-01 2020-12-31 0001670541 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2021-10-01 2021-12-31 0001670541 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2020-10-01 2020-12-31 0001670541 srt:AmericasMember 2021-10-01 2021-12-31 0001670541 srt:AmericasMember 2020-10-01 2020-12-31 0001670541 country:DE 2021-10-01 2021-12-31 0001670541 country:DE 2020-10-01 2020-12-31 0001670541 country:CZ 2021-10-01 2021-12-31 0001670541 country:CZ 2020-10-01 2020-12-31 0001670541 adnt:OtherEMEAExcludingGermanyMember 2021-10-01 2021-12-31 0001670541 adnt:OtherEMEAExcludingGermanyMember 2020-10-01 2020-12-31 0001670541 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2021-10-01 2021-12-31 0001670541 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2020-10-01 2020-12-31 0001670541 us-gaap:EMEAMember 2021-10-01 2021-12-31 0001670541 us-gaap:EMEAMember 2020-10-01 2020-12-31 0001670541 country:TH 2021-10-01 2021-12-31 0001670541 country:TH 2020-10-01 2020-12-31 0001670541 country:CN 2021-10-01 2021-12-31 0001670541 country:CN 2020-10-01 2020-12-31 0001670541 country:JP 2021-10-01 2021-12-31 0001670541 country:JP 2020-10-01 2020-12-31 0001670541 adnt:OtherAsiaExcludingChinaMember 2021-10-01 2021-12-31 0001670541 adnt:OtherAsiaExcludingChinaMember 2020-10-01 2020-12-31 0001670541 us-gaap:IntersegmentEliminationMember srt:AsiaMember 2021-10-01 2021-12-31 0001670541 us-gaap:IntersegmentEliminationMember srt:AsiaMember 2020-10-01 2020-12-31 0001670541 srt:AsiaMember 2021-10-01 2021-12-31 0001670541 srt:AsiaMember 2020-10-01 2020-12-31 0001670541 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-10-01 2021-12-31 0001670541 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2020-10-01 2020-12-31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

| FORM | 10-Q |

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2021
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number: 001-37757

| Adient plc |
| (exact name of Registrant as specified in its charter) |

| Ireland |  | 98-1328821 |
| (State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.) |
| 25-28 North Wall Quay, IFSC, Dublin 1, Ireland D01 H104 |
| (Address of principal executive offices) |
| 734-254-5000 |
| (Registrant's telephone number, including area code) |

Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol | Name of exchange on which registered
Ordinary Shares, par value $0.001 | ADNT | New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer | ☑ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
| ☐ | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑
At December 31, 2021, 94,766,379 ordinary shares were outstanding.

Adient plc
Form 10-Q
For the Three Months Ended December 31, 2021
TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
Item 1. | Unaudited Financial Statements |  | 3
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations |  | 30
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |  | 43
Item 4. | Controls and Procedures |  | 43
PART II - OTHER INFORMATION
Item 1. | Legal Proceedings |  | 44
Item 1A. | Risk Factors |  | 44
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |  | 44
Item 3. | Defaults Upon Senior Securities |  | 44
Item 4. | Mine Safety Disclosures |  | 45
Item 5. | Other Information |  | 45
Item 6. | Exhibits |  | 46
| Signatures |  | 47

Adient plc | Form 10-Q | 2

PART I - FINANCIAL INFORMATION

Item 1. | Unaudited Financial Statements

Adient plc
Consolidated Statements of Income (Loss)
(unaudited)

|  | Three Months Ended December 31, |  |
(in millions, except per share data) |  | 2021 |  | 2020 |  |  |  |
Net sales |  | $ | 3,480 |  |  | $ | 3,848 |  |  |  |  |
Cost of sales |  | 3,307 |  |  | 3,507 |  |  |  |  |
Gross profit |  | 173 |  |  | 341 |  |  |  |  |
Selling, general and administrative expenses |  | 162 |  |  | 149 |  |  |  |  |
Restructuring and impairment costs |  | 4 |  |  | 7 |  |  |  |  |
Equity income (loss) |  | 33 |  |  | 97 |  |  |  |  |
Earnings (loss) before interest and income taxes |  | 40 |  |  | 282 |  |  |  |  |
Net financing charges |  | 50 |  |  | 59 |  |  |  |  |
Other pension expense (income) |  | (1) |  |  | (2) |  |  |  |  |
Income (loss) before income taxes |  | (9) |  |  | 225 |  |  |  |  |
Income tax provision (benefit) |  | 21 |  |  | 52 |  |  |  |  |
Net income (loss) |  | (30) |  |  | 173 |  |  |  |  |
Income (loss) attributable to noncontrolling interests |  | 24 |  |  | 23 |  |  |  |  |
Net income (loss) attributable to Adient |  | $ | (54) |  |  | $ | 150 |  |  |  |  |
Earnings (loss) per share: |  |  |  |  |  |  |  |
Basic |  | $ | (0.57) |  |  | $ | 1.60 |  |  |  |  |
Diluted |  | $ | (0.57) |  |  | $ | 1.58 |  |  |  |  |
Shares used in computing earnings per share: |  |  |  |  |  |  |  |
Basic |  | 94.6 |  |  | 94.0 |  |  |  |  |
Diluted |  | 94.6 |  |  | 94.8 |  |  |  |  |

The accompanying notes are an integral part of the consolidated financial statements.
Adient plc | Form 10-Q | 3

Adient plc
Consolidated Statements of Comprehensive Income (Loss)
(unaudited)

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Net income (loss) |  | $ | (30) |  |  | $ | 173 |  |  |  |  |
Other comprehensive income (loss), net of tax: |  |  |  |  |  |  |  |
Foreign currency translation adjustments |  | 24 |  |  | 72 |  |  |  |  |
Realized and unrealized gains (losses) on derivatives |  | (2) |  |  | 28 |  |  |  |  |
Other comprehensive income (loss) |  | 22 |  |  | 100 |  |  |  |  |
Total comprehensive income (loss) |  | (8) |  |  | 273 |  |  |  |  |
Comprehensive income (loss) attributable to noncontrolling interests |  | 31 |  |  | 40 |  |  |  |  |
Comprehensive income (loss) attributable to Adient |  | $ | (39) |  |  | $ | 233 |  |  |  |  |

The accompanying notes are an integral part of the consolidated financial statements.
Adient plc | Form 10-Q | 4

Adient plc
Consolidated Statements of Financial Position
(unaudited)

(in millions, except share and per share data) |  | December 31, 2021 |  | September 30, 2021
Assets |  |  |  |
Cash and cash equivalents |  | $ | 2,080 |  |  | $ | 1,521 |
Accounts receivable - net |  | 1,597 |  |  | 1,426 |
Inventories |  | 942 |  |  | 976 |
Assets held for sale |  | — |  |  | 49 |
Other current assets |  | 472 |  |  | 1,114 |
Current assets |  | 5,091 |  |  | 5,086 |
Property, plant and equipment - net |  | 1,558 |  |  | 1,607 |
Goodwill |  | 2,209 |  |  | 2,212 |
Other intangible assets - net |  | 549 |  |  | 555 |
Investments in partially-owned affiliates |  | 367 |  |  | 335 |
Assets held for sale |  | 10 |  |  | 25 |
Other noncurrent assets |  | 935 |  |  | 958 |
Total assets |  | $ | 10,719 |  |  | $ | 10,778 |
Liabilities and Shareholders' Equity |  |  |  |
Short-term debt |  | $ | 11 |  |  | $ | 17 |
Current portion of long-term debt |  | 163 |  |  | 167 |
Accounts payable |  | 2,284 |  |  | 2,130 |
Accrued compensation and benefits |  | 315 |  |  | 389 |
Liabilities held for sale |  | — |  |  | 16 |
Restructuring reserve |  | 86 |  |  | 115 |
Other current liabilities |  | 883 |  |  | 677 |
Current liabilities |  | 3,742 |  |  | 3,511 |
Long-term debt |  | 3,482 |  |  | 3,512 |
Liabilities held for sale |  | — |  |  | — |
Pension and postretirement benefits |  | 125 |  |  | 128 |
Other noncurrent liabilities |  | 650 |  |  | 669 |
Long-term liabilities |  | 4,257 |  |  | 4,309 |
Commitments and Contingencies (Note 17) |  |  |  |
Redeemable noncontrolling interests |  | 41 |  |  | 240 |
Preferred shares issued, par value $0.001; 100,000,000 shares authorized, Zero shares issued and outstanding at December 31, 2021 |  | — |  |  | — |
Ordinary shares issued, par value $0.001; 500,000,000 shares authorized, 94,766,379 shares issued and outstanding at December 31, 2021 |  | — |  |  | — |
Additional paid-in capital |  | 3,998 |  |  | 3,991 |
Accumulated deficit |  | (1,042) |  |  | (988) |
Accumulated other comprehensive income (loss) |  | (612) |  |  | (627) |
Shareholders' equity attributable to Adient |  | 2,344 |  |  | 2,376 |
Noncontrolling interests |  | 335 |  |  | 342 |
Total shareholders' equity |  | 2,679 |  |  | 2,718 |
Total liabilities and shareholders' equity |  | $ | 10,719 |  |  | $ | 10,778 |

The accompanying notes are an integral part of the consolidated financial statements.
Adient plc | Form 10-Q | 5

Adient plc
Consolidated Statements of Cash Flows
(unaudited)

|  | Three Months Ended December 31,
(in millions) |  | 2021 |  | 2020
Operating Activities |  |  |  |
Net income (loss) attributable to Adient |  | $ | (54) |  |  | $ | 150 |
Income attributable to noncontrolling interests |  | 24 |  |  | 23 |
Net income (loss) |  | (30) |  |  | 173 |
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: |  |
Depreciation |  | 75 |  |  | 70 |
Amortization of intangibles |  | 13 |  |  | 10 |
Pension and postretirement expense (benefit) |  | 1 |  |  | — |
Pension and postretirement contributions, net |  | (5) |  |  | (9) |
Equity in earnings of partially-owned affiliates, net of dividends received (includes purchase accounting amortization of $1 and $1, respectively) |  | (32) |  |  | (96) |
Derivative loss on the 2021 Yanfeng Transaction |  | 3 |  |  | — |
Deferred income taxes |  | (3) |  |  | (2) |
Non-cash impairment charges |  | 7 |  |  | 6 |
Equity-based compensation |  | 10 |  |  | 13 |
Other |  | 2 |  |  | (3) |
Changes in assets and liabilities: |  |  |  |
Receivables |  | (175) |  |  | 246 |
Inventories |  | 26 |  |  | (6) |
Other assets |  | — |  |  | (78) |
Restructuring reserves |  | (24) |  |  | (53) |
Accounts payable and accrued liabilities |  | 104 |  |  | (84) |
Accrued income taxes |  | 14 |  |  | 44 |
Cash provided (used) by operating activities |  | (14) |  |  | 231 |
Investing Activities |  |  |  |
Capital expenditures |  | (60) |  |  | (71) |
Sale of property, plant and equipment |  | 11 |  |  | 10 |
Settlement of derivatives |  | (30) |  |  | — |
Proceeds from business divestitures |  | 731 |  |  | — |
Cash provided (used) by investing activities |  | 652 |  |  | (61) |
Financing Activities |  |  |  |
Increase (decrease) in short-term debt |  | (6) |  |  | 3 |
Repayment of long-term debt |  | (2) |  |  | (18) |
Dividends paid to noncontrolling interests |  | (59) |  |  | (52) |
Other |  | (12) |  |  | (1) |
Cash provided (used) by financing activities |  | (79) |  |  | (68) |
Effect of exchange rate changes on cash and cash equivalents |  | — |  |  | 25 |
Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale |  | 559 |  |  | 127 |
Change in cash classified within current assets held for sale |  | — |  |  | 1 |
Increase (decrease) in cash and cash equivalents |  | 559 |  |  | 128 |
Cash and cash equivalents at beginning of period |  | 1,521 |  |  | 1,692 |
Cash and cash equivalents at end of period |  | $ | 2,080 |  |  | $ | 1,820 |

The accompanying notes are an integral part of the consolidated financial statements.
Adient plc | Form 10-Q | 6

Adient plc
Notes to Consolidated Financial Statements
(unaudited)

1. Basis of Presentation and Summary of Significant Accounting Policies

Adient is a global leader in the automotive seating supplier industry. Adient has a leading market position in the Americas, Europe and China, and has longstanding relationships with the largest global original equipment manufacturers, or OEMs, in the automotive space. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world.
Basis of Presentation
The consolidated financial statements of Adient have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"). During the second half of fiscal 2021 and continuing into the first quarter of fiscal 2022, Adient faced, along with the entire global automotive industry, widespread supply chain disruptions primarily related to semiconductor chip shortages. Although Adient’s seating products are not highly dependent directly on semiconductor chips, Adient is directly impacted by the lower production levels at OEM’s as a direct result of these supply chain disruptions. These disruptions have led to unplanned down time at Adient’s production facilities, often with very little warning, which creates operating inefficiencies and limits Adient’s ability to adequately mitigate such inefficiencies.
The automotive industry has also experienced a period of sustained price increases for commodities. Shipping costs have also sharply increased throughout fiscal 2021 and remained above historical norms during the first quarter of fiscal 2022. These commodity and shipping cost increases may continue into the future as demand increases and supply may remain constrained, which has resulted in, and may continue to result in, increased costs for Adient that may not be, or may only be partially, offset. Adient is also closely monitoring labor availability and wage inflationary pressures, both internally and at key vendors, to assess any impact labor shortages and wage inflation might have on Adient’s ability to perform its obligations.
Additionally, the impact of COVID-19, and related mutations, continues to be present throughout the world, including in all global and regional markets served by Adient. Although vaccines have been introduced that are expected to have the result of reducing the effect of COVID-19 and COVID-19 started to wane in certain geographic areas, governmental authorities continue to implement numerous measures attempting to contain and mitigate the effects of COVID-19, including travel bans and restrictions, quarantines, social distancing orders, shelter in place orders and shutdowns of non-essential activities. Adient's manufacturing facilities are located in areas that continue to be affected by the pandemic. Adient continues to actively monitor the threat and impacts of COVID-19.
Principles of Consolidation
Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient's interest exceeds 20% and does not have a controlling interest.
Consolidated VIEs
Based upon the criteria set forth in the Financial Accounting Standards Board (the FASB) Accounting Standards Codification (ASC) 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities (VIEs) for the reporting periods ended December 31, 2021, and September 30, 2021, respectively, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.
The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.
The carrying amounts and classification of assets (none of which are restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:
Adient plc | Form 10-Q | 7

(in millions) |  | December 31, 2021 |  | September 30, 2021
Current assets |  | $ | 189 |  |  | $ | 158 |
Noncurrent assets |  | 99 |  |  | 88 |
Total assets |  | $ | 288 |  |  | $ | 246 |
Current liabilities |  | $ | 155 |  |  | $ | 143 |
Noncurrent liabilities |  | 14 |  |  | 8 |
Total liabilities |  | $ | 169 |  |  | $ | 151 |

Earnings Per Share
The following table shows the computation of basic and diluted earnings (loss) per share:

|  | Three Months Ended December 31, |  |
(in millions, except per share data) |  | 2021 |  | 2020 |  |  |  |
Numerator: |  |  |  |  |  |  |  |
Net income (loss) attributable to Adient |  | $ | (54) |  |  | $ | 150 |  |  |  |  |
Denominator: |  |  |  |  |  |  |  |
Shares outstanding |  | 94.6 |  |  | 94.0 |  |  |  |  |
Effect of dilutive securities |  | — |  |  | 0.8 |  |  |  |  |
Diluted shares |  | 94.6 |  |  | 94.8 |  |  |  |  |
Earnings (loss) per share: |  |  |  |  |  |  |  |
Basic |  | $ | (0.57) |  |  | $ | 1.60 |  |  |  |  |
Diluted |  | $ | (0.57) |  |  | $ | 1.58 |  |  |  |  |

The effect of common stock equivalents which would have been anti-dilutive was excluded from the calculation of diluted earnings per share for the three months ended December 31, 2020 and was immaterial. Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share which for the three months ended December 31, 2021 is a result of being in a loss position.
New Accounting Pronouncements
Standards Adopted During Fiscal 2022
On October 1, 2021, Adient adopted Accounting Standards Codification (ASU) 2018-14 Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20). ASU 20218-14 eliminates, adds, and modifies certain disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The guidance is to be applied on a retrospective basis. The adoption of this guidance on October 1, 2021 did not significantly impact Adient's consolidated financial statements for the three months ended December 31, 2021.
On October 1, 2021, Adient adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 modifies ASC 740, Income Taxes, by simplifying accounting for income taxes. As part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements, the FASB’s amendments may impact both interim and annual reporting periods. The adoption of this guidance on October 1, 2021 did not significantly impact Adient's consolidated financial statements for the three months ended December 31, 2021.
Standards Effective After Fiscal 2022
Adient plc | Form 10-Q | 8

Adient has considered the ASUs summarized below, effective after fiscal 2022, none of which is expected to significantly impact the consolidated financial statements:

Standard Adopted |  | Description |  | Date Effective
ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) |  | ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity by reducing the number of accounting models for convertible debt and convertible preferred stock. |  | October 1, 2022
ASU 2021-10, Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance |  | The ASU requires annual disclosures of: i) information about the nature of government assistance transactions and the related accounting policy used to account for the transactions, ii) the balance sheet and income statement line items affected by the transactions, and the amounts for each financial statement line item, and iii) significant transaction terms and conditions. |  | October 1, 2022

2. Revenue Recognition

Adient generates revenue through the sale of automotive seating solutions, including complete seating systems and the components of complete seating systems. Adient provides production and service parts to its customers under awarded multi-year programs. The duration of a program is generally consistent with the life cycle of a vehicle, however, the program can be canceled at any time without cause by the customer. Programs awarded to Adient to supply parts to its customers do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until Adient receives either a purchase order and/or a materials release from the customer for a specific number of parts at a specified price, at which point an enforceable contract exists. Sales revenue is generally recognized at the point in time when parts are shipped and control has transferred to the customer, at which point an enforceable right to payment exists. Contracts may provide for annual price reductions over the production life of the awarded program, and prices are adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors. The amount of revenue recognized reflects the consideration that Adient expects to be entitled to in exchange for such products based on purchase orders, annual price reductions and ongoing price adjustments (some of which are accounted for as variable consideration and subject to being constrained), net of the impact, if any, of consideration paid to the customer.
In a typical arrangement with the customer, purchase orders are issued for pre-production activities which consist of engineering, design and development, tooling and prototypes for the manufacture and delivery of component parts. Adient has concluded that these activities are not in the scope of ASC 606.
Adient has elected to continue to include shipping and handling fees billed to customers in revenue, while including costs of shipping and handling in cost of sales. Taxes collected from customers are excluded from revenue and credited directly to obligations to the appropriate government agencies. Payment terms with customers are established based on customary industry and regional practices. Adient has evaluated the terms of its arrangements and determined that they do not contain significant financing components.
Contract assets primarily relate to the right to consideration for work completed, but not billed at the reporting date on contracts with customers. The contracts assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been satisfied and revenue has not been recognized. No significant contract assets or liabilities were identified at September 30, 2021 or at December 31, 2021. As described above, the issuance of a purchase order and/or a materials release by the customer represents the point at which an enforceable contract with the customer exists. Therefore, Adient has elected to apply the practical expedient in ASC 606, paragraph 606-10-50-14 and does not disclose information about the remaining performance obligations that have an original expected duration of one year or less. Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for disaggregated revenue by geographical market.
Adient plc | Form 10-Q | 9

3. Acquisitions and Divestitures

2021 Yanfeng Transaction
On March 12, 2021, Adient, Yanfeng Automotive Trim Systems Company Ltd. (“Yanfeng”), Yanfeng Adient Seating Co., Ltd. (“YFAS”), a joint venture owned, directly or indirectly, by Yanfeng (50.01%) and Adient (49.99%), and KEIPER Seating Mechanisms Co., Ltd. (f/k/a Adient Yanfeng Seating Mechanisms Co., Ltd. (“AYM” or "KEIPER"), a joint venture owned, directly or indirectly, by Yanfeng (50%) and Adient (50%), entered into a Master Agreement (the “2021 Agreement”), pursuant to which the parties agreed to, among other things, the following transactions (collectively, the “2021 Yanfeng Transaction”). The 2021 Yanfeng Transaction closed on September 30, 2021 (“Closing Date”).
a.Adient transferred all of the issued and outstanding equity interest in YFAS held by Adient, which represents 49.99% of YFAS’s total issued and outstanding equity interest, to Yanfeng pursuant to the Equity Transfer Agreement, dated as of March 12, 2021, by and between Yanfeng and Adient, for CNY ¥8,064 million ($1,210 million), of which ¥3,446 million ($519 million) was paid by Yanfeng to Adient on the Closing Date, and ¥4,618 million ($691 million) was paid by Yanfeng to Adient in December 2021, and;
b.YFAS transferred all of the issued and outstanding equity interests in Yanfeng Adient Automotive Components Co., Ltd. ("CQADNT") and Adient (Langfang) Seating Co., Ltd. ("LFADNT") held directly or indirectly by YFAS to Adient for a price of ¥1,754 million ($271 million) (the “YFAS JVs Acquisition”). The YFAS JVs Acquisition was funded, in part, by annual cash dividends from YFAS and KEIPER, paid to shareholders of YFAS and KEIPER;
c.YFAS transferred all of the issued and outstanding equity interest in Yanfeng Adient Founder Motor Co., Ltd. (“YFM”) held, directly or indirectly, by YFAS, which represented 70% of YFM’s total issued and outstanding equity interest, to KEIPER for ¥71 million ($11 million) (the “YFM Sale”);
d.YFAS transferred all of the issued and outstanding equity interest in Nantong Yanfeng Adient Seating Trim Co., Ltd. (“YFAT”) held, directly or indirectly, by YFAS, which represented 75% of YFAT’s total issued and outstanding equity interest, to KEIPER for ¥113 million ($17 million) (the “YFAT Sale”);
e.Adient granted to Yanfeng a license of intellectual property for use on a non-exclusive and perpetual basis for a payment of ¥385 million ($59 million), and Yanfeng/YFAS granted to Adient a royalty-free, non-exclusive and perpetual intellectual property license of the Yanfeng/YFAS intellectual property; and
f.YFAS declared and distributed dividends in the amounts and at the times as set forth in the 2021 Agreement to its shareholders (proportionately to their ownership interest, namely 50.01% to Yanfeng and 49.99% to Adient) of approximately ¥4,168 million ($635 million) in the aggregate. YFAS paid an aggregate dividend of ¥2,809 million ($436 million) during the third quarter of fiscal 2021, and ¥1,359 million ($199 million) was distributed on the Closing Date.
In addition, on March 12, 2021, Adient, YFAS, Yanfeng and KEIPER, entered into an Ancillary Master Agreement (the “Ancillary Master Agreement”), pursuant to which the parties have agreed to, among other things, the following transactions (collectively, the “Ancillary Transactions”). The Ancillary Transactions were also completed on the Closing Date.
a.Adient and Yanfeng amended the KEIPER Equity Joint Venture Contract, dated as of January 31, 2020, as amended, and the Articles of Association of KEIPER, dated as of September 9, 2013, as amended, to, among other things, (i) provide that KEIPER would declare and pay certain annual dividends to KEIPER’s shareholders with respect to each of its 2021 to 2023 fiscal years and (ii) upon closing of the earlier of the YFAT Sales (as defined below) or YFM Sale, because of KEIPER’s ownership of YFAT and YFM, certain amendments relating thereto, including modifying the scope of KEIPER’s business to include the manufacture and sale of automotive seat trim products and micro-motors; and
b.KEIPER and Yanfeng and KEIPER and Adient each entered into a long-term supply agreement.
In conjunction with the 2021 Yanfeng Transaction, Adient entered into an agreement (the “Boxun Agreement”) with Chongqing Boxun Industrial Co., Ltd. (“Boxun”). Pursuant to such agreement, upon consummation of the YFAS JVs Acquisition, Adient has provided Boxun with the right to sell and, if exercised, Adient has agreed to purchase, all of the issued and outstanding equity interest in CQADNT held by Boxun, which represents 25% of CQADNT’s total issued and outstanding equity interest (the “Boxun Equity Purchase”) for approximately ¥825 million ($124 million), subject to adjustment as set forth
Adient plc | Form 10-Q | 10

in the Boxun Agreement. On October 29, 2021, Boxun exercised its right to sell its equity interest to Adient. In January 2022, Boxun and Adient closed the transaction. The total payment to Boxun from Adient is approximately $200 million ($15 million of historical dividends paid in December 2021, $170 million paid in Jaunary 2022, and $15 million to be paid in the second quarter of fiscal 2022 after completion of the 2021 financial audit). The approximate $200 million payment to Boxun includes the value of the Boxun Equity Purchase along with historical dividends and other payments, of which $194 million had been reflected as redeemable noncontrolling interest at September 30, 2021. At December 31, 2021, Adient reclassifed the redeemable noncontrolling interest balance of $186 million, which is net of $15 million of historical dividends paid in December 2021, to other current liabilities as the obligation was determined to be unconditional. With the acquisitions of Boxun’s 25% and YFAS’s 50% interest of CQADNT, Adient owns 100% of CQADNT effective January 2022.
In addition, in conjunction with the 2021 Yanfeng Transaction, Adient entered into agreements, whereby, Adient would: (i) transfer all of the issued and outstanding equity interest in YFAT held, directly or indirectly, by Adient, which represents 25% of YFAT’s total issued and outstanding equity interest, to KEIPER for ¥38 million ($6 million) (the “Adient YFAT Sale” and together with the YFAT Sale, the “YFAT Sales”); (ii) transfer all of the issued and outstanding equity interest in Guangzhou Dongfeng Adient Seating Co., Ltd. (“GZDFAS”) held by Adient, which represents 25% of GZDFAS’s total issued and outstanding equity interest, to YFAS for ¥371 million ($56 million) (the “GZDFAS Sale”) and (iii) transfer all of the issued and outstanding equity interest in Hefei Adient Yunhe Automotive Seating Co., Ltd. (“YHAS”) held by Adient, which represents 10% of YHAS’s total issued and outstanding equity interest, to YFAS for ¥13 million ($2 million) (the “YHAS Sale,” together with the Adient YFAT Sale and GZDFAS Sale, each an “Additional Equity Sale” and collectively, the “Additional Equity Sales”). The Additional Equity Sales were completed on the Closing Date.
As a result of the 2021 Agreement, Adient received $41 million in November 2021 representing the remaining balance of proceeds from the sale of its interest in Yanfeng Global Automotive Interior Systems Co. ("YFAI"), a joint venture previously owned, directly or indirectly, by Yanfeng (70%) and Adient (30%), which was part of the 2020 Yanfeng Transaction (as defined and described in Form 10-K for the fiscal year ended September 30, 2021).
Upon completion of the 2021 Yanfeng Transaction on September 30, 2021, Adient started consolidating CQADNT and LFADNT. The net purchase consideration of $271 million consisted of net cash consideration of $211 million, net of $60 million acquired. The acquisition was accounted for using the acquisition method, and the operating results and cash flows of CQADNT and LFADNT will be included in Adient's consolidated financial statements starting from October 1, 2021. The acquisitions are expected to provide substantial synergies through vertical integration, purchasing and logistics improvements. The acquisitions also provide for an immediate manufacturing presence in strategic locations in China.
Adient recorded a purchase price allocation for the assets acquired and liabilities assumed based on their estimated fair values as of the September 30, 2021 acquisition date. The preliminary purchase price adjustments and allocation is as follows:

|  | Fair value allocation
(in millions) |  | CQADNT |  | LFADNT
Cash |  | $ | 55 |  |  | $ | 5 |
Accounts receivable |  | 296 |  |  | 2 |
Inventory |  | 37 |  |  | 5 |
Property, plant and equipment |  | 86 |  |  | 8 |
Other assets |  | 46 |  |  | 2 |
Goodwill |  | 180 |  |  | 8 |
Intangible assets |  | 234 |  |  | 6 |
Accounts payable |  | (252) |  |  | (19) |
Other liabilities |  | (127) |  |  | (4) |
Subtotal |  | 555 |  |  | 13 |
Less: Interest already owned |  | 103 |  |  | — |
Less: Redeemable noncontrolling interest |  | 194 |  |  | — |
Total purchase consideration |  | 258 |  |  | 13 |
Less: cash acquired |  | 55 |  |  | 5 |
Net cash paid |  | $ | 203 |  |  | $ | 8 |

Adient plc | Form 10-Q | 11

The values allocated to CQADNT and LFADNT’s intangible assets of $234 million and $6 million, respectively, primarily consisted of customer relationships and patented technologies which are being amortized on a straight line basis over estimated useful lives of 3 to 12 years. The assets were valued using a combination of an income approach and a relief from royalty approach. These values were considered level 3 measurements under the U.S. GAAP fair value hierarchy. Key assumptions used in the valuation of customer relationships included a rate of return of 13.5% and the life of the relationship of approximately 12 years. Key assumptions used in the valuation of patented technologies included a rate of return of 13.5% and the life of the technologies of approximately 10 years.
The allocation of the purchase price was based on the valuations performed to determine the fair value of the net assets as of the acquisition date. The amounts allocated to goodwill and intangible assets along with fair value adjustments on property, plant and equipment and inventory reflected preliminary valuations.
SJA
On March 31, 2021, Adient sold its 50% equity interest in Shenyang Jinbei Adient Automotive Components Co., Ltd. ("SJA") to the joint venture partner for $58 million, which resulted in a $33 million one-time gain recognized during the second quarter of fiscal 2021. The receivable was recorded as part of other current assets on March 31, 2021, and the net proceeds of $53 million were received on April 1, 2021.
Assets held for sale
During the first quarter of fiscal 2022, Adient committed to sell certain assets in EMEA. As a result these assets were classified as assets held for sale and were required to be adjusted to the lower of fair value less cost to sell or carrying value. This resulted in an impairment charge of $7 million, which was recorded within restructuring and impairment costs on the consolidated statement of income (loss) in the first quarter of fiscal 2022. The impairment was measured using third party sales pricing to determine fair values of the assets. The inputs utilized in the analyses are classified as Level 3 inputs within the fair value hierarchy as defined in ASC 820, "Fair Value Measurement."
During fiscal 2021, Adient committed to sell certain assets in France and Turkey. As a result, these assets were classified as assets held for sale (including an allocation of $11 million of goodwill) and were required to be adjusted to the lower of fair value less cost to sell or carrying value. This resulted in Adient recording an impairment charge of $9 million within restructuring and impairment costs on the consolidated statement of income (loss) related to the assets in France. The impairment was measured using third party sales pricing to determine fair values of the assets. The inputs utilized in the analyses are classified as Level 3 inputs within the fair value hierarchy as defined in ASC 820, "Fair Value Measurement." The sale of the assets in France was completed during the third quarter of fiscal 2021 for minimal proceeds while the sale of the assets in Turkey was completed in October 2021 for total expected proceeds of $48 million, of which $36 million was collected at closing.

4. Inventories

Inventories consisted of the following:

(in millions) |  | December 31, 2021 |  | September 30, 2021
Raw materials and supplies |  | $ | 733 |  |  | $ | 750 |
Work-in-process |  | 27 |  |  | 29 |
Finished goods |  | 182 |  |  | 197 |
Inventories |  | $ | 942 |  |  | $ | 976 |

Adient plc | Form 10-Q | 12

5. Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill are as follows:

(in millions) |  | Americas |  | EMEA |  | Asia |  | Total |  |  |  |  |
Balance at September 30, 2021 |  | $ | 607 |  |  | $ | 354 |  |  | $ | 1,251 |  |  | $ | 2,212 |  |  |  |  |  |
Currency translation and other |  | (1) |  |  | (10) |  |  | 8 |  |  | (3) |  |  |  |  |  |
Balance at December 31, 2021 |  | $ | 606 |  |  | $ | 344 |  |  | $ | 1,259 |  |  | $ | 2,209 |  |  |  |  |  |

Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for more information on Adient's reportable segments.
Adient's other intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:

|  | December 31, 2021 |  | September 30, 2021
(in millions) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net
Intangible assets |  |  |  |  |  |  |  |  |  |  |  |
Patented technology |  | $ | 86 |  |  | $ | (20) |  |  | $ | 66 |  |  | $ | 86 |  |  | $ | (19) |  |  | $ | 67 |
Customer relationships |  | 655 |  |  | (188) |  |  | 467 |  |  | 649 |  |  | (178) |  |  | 471 |
Trademarks |  | 25 |  |  | (21) |  |  | 4 |  |  | 26 |  |  | (21) |  |  | 5 |
Miscellaneous |  | 24 |  |  | (12) |  |  | 12 |  |  | 24 |  |  | (12) |  |  | 12 |
Total intangible assets |  | $ | 790 |  |  | $ | (241) |  |  | $ | 549 |  |  | $ | 785 |  |  | $ | (230) |  |  | $ | 555 |

Amortization of other intangible assets for the three months ended December 31, 2021 and 2020 was $13 million and $10 million, respectively.
Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for more information on Adient's reportable segments.

6. Product Warranties

Adient offers warranties to its customers depending upon the specific product and terms of the customer purchase agreement. A typical warranty program requires that Adient replace defective products within a specified time period from the date of sale. Adient records an estimate for future warranty-related costs based on actual historical return rates and other known factors. Based on analysis of return rates and other factors, Adient's warranty provisions are adjusted as necessary. Adient monitors its warranty activity and adjusts its reserve estimates when it is probable that future warranty costs will be different than those estimates. Adient's product warranty liability is recorded in the consolidated statements of financial position in other current liabilities.
The changes in Adient's total product warranty liability are as follows:

|  | Three Months Ended December 31,
(in millions) |  | 2021 |  | 2020
Balance at beginning of period |  | $ | 23 |  |  | $ | 24 |
Accruals for warranties issued during the period |  | 2 |  |  | 3 |
Changes in accruals related to pre-existing warranties (including changes in estimates) |  | 1 |  |  | (1) |
Settlements made (in cash or in kind) during the period |  | (3) |  |  | (2) |
Balance at end of period |  | $ | 23 |  |  | $ | 24 |

Adient plc | Form 10-Q | 13

7. Leases

Adient's lease portfolio consists of operating leases for real estate including production facilities, warehouses and administrative offices, equipment such as forklifts and computer servers and laptops, and fleet vehicles.
The components of lease costs included in the consolidated statement of income (loss) for the three months ended December 31, 2021 and 2020 were as follows:

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Operating lease cost |  | $ | 30 |  |  | $ | 30 |  |  |  |  |
Short-term lease cost |  | 5 |  |  | 6 |  |  |  |  |
Total lease cost |  | $ | 35 |  |  | $ | 36 |  |  |  |  |

Operating lease right-of-use assets and lease liabilities included in the consolidated statement of financial position were as follows:

(in millions) |  |  |  | December 31, 2021 |  | September 30, 2021
Operating leases: |  |  |  |  |  |
Operating lease right-of-use assets |  | Other noncurrent assets |  | $ | 320 |  | $ | 335
Operating lease liabilities - current |  | Other current liabilities |  | $ | 89 |  | $ | 89
Operating lease liabilities - noncurrent |  | Other noncurrent liabilities |  | 231 |  | 246
|  |  |  | $ | 320 |  | $ | 335
Weighted average remaining lease term: |  |  |  |  |  |
Operating leases |  |  |  | 6 years |  | 6 years
Weighted average discount rate: |  |  |  |  |  |
Operating leases |  |  |  | 5.1 | % |  | 5.2 | %

Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of December 31, 2021 were as follows:

|  | Operating leases
Fiscal years (in millions) |  | December 31, 2021 |  |
2021 (excluding the three months ended December 31, 2021) |  | $ | 83 |  |  |
2022 |  | 88 |  |  |
2023 |  | 65 |  |  |
2024 |  | 45 |  |  |
2025 |  | 29 |  |  |
Thereafter |  | 78 |  |  |
Total lease payments |  | 388 |  |  |
Less: imputed interest |  | (68) |  |  |
Present value of lease liabilities |  | $ | 320 |  |  |

Supplemental cash flow information related to leases was as follows:
Adient plc | Form 10-Q | 14

|  | Three Months Ended December 31,
(in millions) |  | 2021 |  | 2020
Right-of-use assets obtained in exchange for lease obligations: |  |  |  |
Operating leases (non-cash activity) |  | $ | 10 |  |  | $ | 24 |
Operating cash flows: |  |  |  |
Cash paid for amounts included in the measurement of lease liabilities |  | $ | 29 |  |  | $ | 29 |

8. Debt and Financing Arrangements

Debt consisted of the following:

(in millions) |  | December 31, 2021 |  | September 30, 2021
Long-term debt: |  |  |  |
Term Loan B - LIBOR plus 3.50% due in 2028 |  | $ | 995 |  |  | $ | 998 |
4.875% Notes due in 2026 |  | 795 |  |  | 795 |
3.50% Notes due in 2024 |  | 1,132 |  |  | 1,161 |
9.00% Notes due in 2025 |  | 600 |  |  | 600 |
European Investment Bank Loan - EURIBOR plus 1.58% due in 2022 |  | 152 |  |  | 156 |
Finance lease obligations |  | 1 |  |  | 1 |
Less: debt issuance costs |  | (30) |  |  | (32) |
Gross long-term debt |  | 3,645 |  |  | 3,679 |
Less: current portion |  | 163 |  |  | 167 |
Net long-term debt |  | $ | 3,482 |  |  | $ | 3,512 |
Short-term debt: |  |  |  |
Other bank borrowings |  | $ | 11 |  |  | $ | 17 |
Total short-term debt |  | $ | 11 |  |  | $ | 17 |

Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintains an asset-based revolving credit facility (the “ABL Credit Facility”), which provides for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity. The ABL Credit Facility will mature on May 6, 2024, subject to a springing maturity date 91 days earlier if certain amounts remain outstanding at that time under the Term Loan B Agreement (defined below). Adient will pay a commitment fee of 0.25% to 0.375% on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the ABL Credit Facility then in effect. Subject to certain conditions, the ABL Credit Facility may be expanded by up to $250 million in additional commitments. Loans under the ABL Credit Facility may be denominated, at the option of Adient, in U.S. dollars, Euros, Pounds Sterling or Swedish Kroner. The ABL Credit Agreement is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. On November 24, 2021, Adient entered into an amendment to its ABL Credit Facility (the “ABL Amendment”) to amend certain terms and provisions, including to (i) change the interest rate benchmark rates applicable under the ABL Credit Facility for borrowings denominated in euro, Swedish krona and pounds sterling to EURIBOR, STIBOR, and SONIA, in each case subject to certain adjustments, and (ii) update the provisions in our ABL Credit Facility by which U.S. dollar LIBOR will eventually be replaced with SOFR or another interest rate benchmark, in each case, to reflect the most recent standards and practices used in the industry. Interest is payable on the ABL Credit Facility at a fluctuating rate of interest determined by reference to LIBOR, in the case of amounts outstanding in dollars, EURIBOR, in the case of amounts outstanding in euros, STIBOR, in the case of
Adient plc | Form 10-Q | 15

amounts outstanding in Swedish krona and SONIA, in the case of amounts outstanding in pounds sterling, in each case, plus an applicable margin of 1.50% to 2.00%. As of December 31, 2021, Adient had not drawn down on the ABL Credit Facility and had availability under this facility of $880 million (net of $59 million of letters of credit).
In addition, Adient US and Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintain a term loan credit agreement (the “Term Loan B Agreement”) that initially provided for a 5-year $800 million senior secured term loan facility that was fully drawn on closing. The Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance originally due at final maturity on May 6, 2024. Interest on the Term Loan B Agreement accrues at the Eurodollar rate plus an applicable margin originally equal to 4.25% (with one 0.25% step down based on achievement of a specific secured net leverage level starting with the fiscal quarter ending December 31, 2019). The Term Loan B Agreement also permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions. In April 2021, Adient amended the Term Loan B Agreement ("Amended Agreement") which, among other changes (i) extended the maturity date for loans outstanding to April 8, 2028, (ii) reduced the interest rate margin applicable thereunder by 0.75% to 3.50%, in the case of Eurodollar Rate loans, and 2.50% (in the case of Base Rate loans) (in each case, with one 0.25% step down based on achievement of a specified first lien secured net leverage level starting with the fiscal quarter ending December 31, 2021) and (iii) made certain other negative covenant and mandatory prepayment changes in connection therewith. The amendment also established incremental term loans in an aggregate principal amount of $214 million resulting in total loans outstanding under the Amended Agreement of $1.0 billion. Adient paid $7 million related to the Amended Agreement and wrote off $8 million of previously deferred financing costs as a result of the debt extinguishment during the third quarter of fiscal 2021.
Adient US was also a party to an indenture relating to the issuance of $800 million aggregate principal amount of Senior First Lien Notes. The notes originally mature on May 15, 2026 and bore interest at a rate of 7.00% per annum. Interest on these notes was payable semi-annually in arrears on November 15 and May 15 of each year, commencing on November 15, 2019. During the second quarter of fiscal 2021, Adient repurchased $640 million of the outstanding balance of the Senior First Lien Notes at a price of 107% of the principal plus $17 million of accrued and unpaid interest. As a result, $9 million of previously deferred financing costs was written off to net financing charges. During the third quarter of fiscal 2021, Adient redeemed the $160 million of remaining balance of the Senior First Lien Notes at a price of 103% of the principal plus $4 million of accrued and unpaid interest, and wrote off $3 million of previously deferred financing costs as a result of the debt extinguishment.
The ABL Credit Facility, Term Loan B Agreement and the Senior First Lien Notes due 2026 contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient’s capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient’s and its restricted subsidiaries’ assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.
Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, maintains $900 million aggregate principal amount of 4.875% USD-denominated unsecured notes due 2026. During the fourth quarter of fiscal 2020, Adient redeemed $103 million of face value of these notes, resulting in a remaining balance of $797 million as of September 30, 2020. Adient further redeemed $2 million of the notes during fiscal 2021, resulting in a remaining balance of $795 million as of September 2021. AGH also maintains €1.0 billion aggregate principal amount of 3.50% unsecured notes due 2024. In January 2022, Adient commenced a cash tender offer for up to €177 million of the 3.50% unsecured notes due 2024.
Adient Germany Ltd. & Co. KG, a wholly owned subsidiary of Adient, maintains €135 million in an unsecured term loan from the European Investment Bank ("EIB") due in 2022. The loan bears interest at the 6-month EURIBOR rate plus 158 basis points. Adient is compliant with the net leverage ratio of 4.5x at December 31, 2021 and expects to be compliant during the remainder of the term. During the first quarter of fiscal 2021, Adient repaid $16 million of the EIB loan, triggered in part by the redemption of debt in the prior year. Adient repaid $20 million of the EIB loan in May 2021, triggered by the prior year sale of the fabrics business.
On April 20, 2020, Adient US issued $600 million (net proceeds of $591 million) aggregate principal amount of 9.00% Senior First Lien Notes due 2025. These notes will mature on April 15, 2025, provided that if AGH has not refinanced (or otherwise redeemed) in whole its outstanding 3.50% unsecured notes due 2024 or any refinancing indebtedness thereof that matures
Adient plc | Form 10-Q | 16

earlier than 91 days prior to the maturity date of the Senior First Lien Notes due 2025 on or prior to May 15, 2024, these notes will mature on May 15, 2024. Interest on these notes is due on April 15 and October 15 each year, beginning on October 15, 2020. These notes contain covenants that are usual and customary, similar to the covenants on the Senior First Lien Notes due 2026 as described above. Adient incurred $10 million of debt issuance cost associated with this new debt in fiscal 2020. In January 2022, Adient commenced a cash tender offer for any and all of the Senior First Lien Notes due 2025.
Net Financing Charges
Adient's net financing charges in the consolidated statements of income (loss) contained the following components:

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Interest expense, net of capitalized interest costs |  | $ | 46 |  |  | $ | 59 |  |  |  |  |
Banking fees and debt issuance cost amortization |  | 3 |  |  | 3 |  |  |  |  |
Interest income |  | (2) |  |  | (2) |  |  |  |  |
Derivative loss on Yanfeng transaction |  | 3 |  |  | — |  |  |  |  |
Net foreign exchange |  | — |  |  | (1) |  |  |  |  |
Net financing charges |  | $ | 50 |  |  | $ | 59 |  |  |  |  |

Total interest paid on both short and long-term debt for the three months ended December 31, 2021 and 2020 was $41 million and $66 million, respectively.

9. Derivative Instruments and Hedging Activities

Adient selectively uses derivative instruments to reduce Adient's market risk associated with changes in foreign currency. Under Adient's policy, the use of derivatives is restricted to those intended for hedging purposes; the use of any derivative instrument for speculative purposes is strictly prohibited. A description of each type of derivative utilized to manage Adient's risk is included in the following paragraphs. In addition, refer to Note 10, "Fair Value Measurements," of the notes to consolidated financial statements for information related to the fair value measurements and valuation methods utilized by Adient for each derivative type.
Adient has global operations and participates in the foreign exchange markets to minimize its risk of loss from fluctuations in foreign currency exchange rates. Adient primarily uses foreign currency exchange contracts to hedge certain foreign exchange rate exposures. Adient hedges 70% to 90% of the nominal amount of each of its known foreign exchange transactional exposures. Gains and losses on derivative contracts offset gains and losses on underlying foreign currency exposures. These contracts have been designated as cash flow hedges under ASC 815, "Derivatives and Hedging," and the hedge gains or losses due to changes in fair value are initially recorded as a component of accumulated other comprehensive income (AOCI) and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. All contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at December 31, 2021 and September 30, 2021, respectively.
As of December 31, 2021, the €1.0 billion aggregate principal amount of 3.50% euro-denominated unsecured notes due 2024 was designated as a net investment hedge to selectively hedge portions of Adient's net investment in Europe. The currency effects of Adient's euro-denominated bonds are reflected in the AOCI account within shareholders' equity attributable to Adient where they offset gains and losses recorded on Adient's net investment in Europe.
Adient entered into a cross-currency interest rate swap during fiscal 2019 to selectively hedge portions of its net investment in Japan. The currency effects of the cross-currency interest rate swap is reflected in the AOCI account within shareholders' equity attributable to Adient, where they offset gains and losses recorded on Adient's net investment in Japan. The contract matured during the fourth quarter of fiscal 2021. As of December 31, 2021, there was no outstanding Japanese yen denominated cross-currency interest rate swap.
Adient purchased interest rate caps during fiscal 2019 to selectively limit the impact of USD LIBOR increases on its interest payments related to Adient's Term Loan B Agreement. The interest rate caps were designated as cash flow hedges under ASC
Adient plc | Form 10-Q | 17

815. As of December 31, 2021, Adient had two outstanding interest rate caps with total notional amount of approximately $200 million. During the third quarter of fiscal 2021, in conjunction with the Term Loan B Amendment as discussed in Note 8, "Debt and Financing Arrangements," Adient de-designated these two contracts, the impact of which was not material.
The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:

|  | Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815 |  | Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815
(in millions) |  | December 31, 2021 |  | September 30, 2021 |  | December 31, 2021 |  | September 30, 2021
Other current assets |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | $ | 6 |  |  | $ | 8 |  |  | $ | 5 |  |  | $ | — |
Other noncurrent assets |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | — |  |  | — |  |  | 1 |  |  | 1 |
Total assets |  | $ | 6 |  |  | $ | 8 |  |  | $ | 6 |  |  | $ | 1 |
Other current liabilities |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | $ | 13 |  |  | $ | 11 |  |  | $ | — |  |  | $ | 13 |
Other noncurrent liabilities |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | 3 |  |  | 4 |  |  | — |  |  | — |
Long-term debt |  |  |  |  |  |  |  |
Foreign currency denominated debt |  | 1,132 |  |  | 1,161 |  |  | — |  |  | — |
Total liabilities |  | $ | 1,148 |  |  | $ | 1,176 |  |  | $ | — |  |  | $ | 13 |

Adient enters into International Swaps and Derivatives Associations (ISDA) master netting agreements with counterparties that permit the net settlement of amounts owed under the derivative contracts. The master netting agreements generally provide for net settlement of all outstanding contracts with a counterparty in the case of an event of default or a termination event. Adient has not elected to offset the fair value positions of the derivative contracts recorded in the consolidated statements of financial position. Collateral is generally not required of Adient or the counterparties under the master netting agreements. As of December 31, 2021 and September 30, 2021, no cash collateral was received or pledged under the master netting agreements.
The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:

|  | Assets |  | Liabilities
(in millions) |  | December 31, 2021 |  | September 30, 2021 |  | December 31, 2021 |  | September 30, 2021
Gross amount recognized |  | $ | 12 |  |  | $ | 9 |  |  | $ | 1,148 |  |  | $ | 1,189 |
Gross amount eligible for offsetting |  | (8) |  |  | (9) |  |  | (8) |  |  | (9) |
Net amount |  | $ | 4 |  |  | $ | — |  |  | $ | 1,140 |  |  | $ | 1,180 |

The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income related to cash flow hedges:

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Foreign currency exchange derivatives |  | $ | (2) |  |  | $ | 30 |  |  |  |  |

Adient plc | Form 10-Q | 18

The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income:

(in millions) |  |  |  | Three Months Ended December 31, |  |
|  | 2021 |  | 2020 |  |  |  |
Foreign currency exchange derivatives |  | Cost of sales |  | $ | 1 |  |  | $ | (5) |  |  |  |  |

The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):

(in millions) |  |  |  | Three Months Ended December 31, |  |
|  | 2021 |  | 2020 |  |  |  |
Foreign currency exchange derivatives |  | Cost of sales |  | $ | 1 |  |  | $ | — |  |  |  |  |
Foreign currency exchange derivatives |  | Net financing charges |  | (15) |  |  | 2 |  |  |  |  |
Total |  |  |  | $ | (14) |  |  | $ | 2 |  |  |  |  |

The effective portion of pretax gains (losses) recorded in currency translation adjustment (CTA) within other comprehensive income (loss) related to net investment hedges was $29 million and $(58) million for the three months ended December 31, 2021 and 2020, respectively. For the three months ended December 31, 2021 and 2020, no gains or losses were reclassified from CTA into income for Adient's outstanding net investment hedges. For the three months ended December 31, 2021 and 2020, no ineffectiveness was recognized in the consolidated statements of income (loss) resulting from cash flow hedges.

10. Fair Value Measurements

ASC 820, "Fair Value Measurement," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-level fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability as follows:
Level 1: Observable inputs such as quoted prices in active markets;
Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3: Unobservable inputs where there is little or no market data, which requires the reporting entity to develop its own assumptions.
ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.
Adient plc | Form 10-Q | 19

Recurring Fair Value Measurements
The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:

|  | Fair Value Measurements Using:
(in millions) |  | Total as of December 31, 2021 |  | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Other current assets |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | $ | 11 |  |  | $ | — |  |  | $ | 11 |  |  | $ | — |
Other noncurrent assets |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | 1 |  |  | — |  |  | 1 |  |  | — |
Total assets |  | $ | 12 |  |  | $ | — |  |  | $ | 12 |  |  | $ | — |
Other current liabilities |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | $ | 13 |  |  | $ | — |  |  | $ | 13 |  |  | $ | — |
Other noncurrent liabilities |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | 3 |  |  | — |  |  | 3 |  |  | — |
Total liabilities |  | $ | 16 |  |  | $ | — |  |  | $ | 16 |  |  | $ | — |

|  | Fair Value Measurements Using:
(in millions) |  | Total as of September 30, 2021 |  | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Other current assets |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | $ | 8 |  |  | $ | — |  |  | $ | 8 |  |  | $ | — |
Other noncurrent assets |  |  |  |  |  |  |  |
Interest rate cap |  | 1 |  |  | — |  |  | 1 |  |  | — |
Total assets |  | $ | 9 |  |  | $ | — |  |  | $ | 9 |  |  | $ | — |
Other current liabilities |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | $ | 24 |  |  | $ | — |  |  | $ | 24 |  |  | $ | — |
Cross-currency interest rate swaps |  | — |  |  | — |  |  | — |  |  | — |
Other noncurrent liabilities |  |  |  |  |  |  |  |
Foreign currency exchange derivatives |  | 4 |  |  | — |  |  | 4 |  |  | — |
Total liabilities |  | $ | 28 |  |  | $ | — |  |  | $ | 28 |  |  | $ | — |

Valuation Methods
Foreign currency exchange derivatives Adient selectively hedges anticipated transactions and net investments that are subject to foreign exchange rate risk primarily using foreign currency exchange hedge contracts. The foreign currency exchange derivatives are valued under a market approach using publicized spot and forward prices. Changes in fair value on foreign exchange derivatives accounted for as hedging instruments under ASC 815 are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. These contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at December 31, 2021 and September 30, 2021, respectively. The changes in fair value of foreign currency exchange derivatives not designated as hedging instruments under ASC 815 are recorded in the consolidated statements of income.
Cross-currency interest rate swaps Adient determines the fair value of a cross-currency interest rate swap contract using a market approach which is based on quoted market price for similar instruments in markets. All significant inputs are
Adient plc | Form 10-Q | 20

corroborated by observable market data for the term of such a contract. Adient selectively uses cross-currency interest rate swaps to hedge portions of its net investments. As of December 31, 2021, Adient had no cross-currency interest rate swap outstanding.
Interest rate caps Adient determines the fair value of an interest rate cap contract using a market approach which is based on quoted market price for identical or similar instruments in markets. All significant inputs are corroborated by observable market data for the term of such a contract. Adient selectively uses interest rate caps to limit the impact of floating rate interest payment increases on its Term Loan B Agreement. As of December 31, 2021, Adient had two interest rate caps outstanding totaling approximately $200 million.
The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The fair value of long-term debt, which was $3.7 billion a nd $3.8 billion at December 31, 2021 and September 30, 2021, respectively, was determined primarily using market quotes classified as Level 1 inputs within the ASC 820 fair value hierarchy.

11. Equity and Noncontrolling Interests

For the three months ended December 31, 2021:

(in millions) |  | Ordinary Shares |  | Additional Paid-in Capital |  | Retained Earnings (Accumulated Deficit) |  |  |  | Accumulated Other Comprehensive Income (Loss) |  | Shareholders' Equity Attributable to Adient |  | Shareholders' Equity Attributable to Noncontrolling Interests |  | Total Equity
Balance at September 30, 2021 |  | $ | — |  |  | $ | 3,991 |  |  | $ | (988) |  |  |  |  | $ | (627) |  |  | $ | 2,376 |  |  | $ | 342 |  |  | $ | 2,718 |
Net income (loss) |  | — |  |  | — |  |  | (54) |  |  |  |  | — |  |  | (54) |  |  | 11 |  |  | (43) |
Foreign currency translation adjustments |  | — |  |  | — |  |  | — |  |  |  |  | 17 |  |  | 17 |  |  | 2 |  |  | 19 |
Realized and unrealized gains (losses) on derivatives |  | — |  |  | — |  |  | — |  |  |  |  | (2) |  |  | (2) |  |  | — |  |  | (2) |
Dividends attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | (8) |  |  | (8) |
Purchase of subsidiary shares from noncontrolling interest |  | — |  |  | 12 |  |  | — |  |  |  |  | — |  |  | 12 |  |  | (12) |  |  | — |
Share based compensation and other |  | — |  |  | (5) |  |  | — |  |  |  |  | — |  |  | (5) |  |  | — |  |  | (5) |
Balance at December 31, 2021 |  | $ | — |  |  | $ | 3,998 |  |  | $ | (1,042) |  |  |  |  | $ | (612) |  |  | $ | 2,344 |  |  | $ | 335 |  |  | $ | 2,679 |

For the three months ended December 31, 2020:

(in millions) |  | Ordinary Shares |  | Additional Paid-in Capital |  | Retained Earnings (Accumulated Deficit) |  |  |  | Accumulated Other Comprehensive Income (Loss) |  | Shareholders' Equity Attributable to Adient |  | Shareholders' Equity Attributable to Noncontrolling Interests |  | Total Equity
Balance at September 30, 2020 |  | $ | — |  |  | $ | 3,974 |  |  | $ | (2,096) |  |  |  |  | $ | (665) |  |  | $ | 1,213 |  |  | $ | 322 |  |  | $ | 1,535 |
Net income (loss) |  | — |  |  | — |  |  | 150 |  |  |  |  | — |  |  | 150 |  |  | 17 |  |  | 167 |
Foreign currency translation adjustments |  | — |  |  | — |  |  | — |  |  |  |  | 55 |  |  | 55 |  |  | 10 |  |  | 65 |
Realized and unrealized gains (losses) on derivatives |  | — |  |  | — |  |  | — |  |  |  |  | 28 |  |  | 28 |  |  | — |  |  | 28 |
Dividends attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | — |  |  | (4) |  |  | (4) |
Share based compensation and other |  | — |  |  | 8 |  |  | — |  |  |  |  | — |  |  | 8 |  |  | — |  |  | 8 |
Adjustments from adoption of a new standard |  | — |  |  | (2) |  |  | — |  |  |  |  | — |  |  | (2) |  |  | — |  |  | (2) |
Balance at December 31, 2020 |  | $ | — |  |  | $ | 3,980 |  |  | $ | (1,946) |  |  |  |  | $ | (582) |  |  | $ | 1,452 |  |  | $ | 345 |  |  | $ | 1,797 |

Adient plc | Form 10-Q | 21

The following table presents changes in AOCI attributable to Adient:

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Foreign currency translation adjustments |  |  |  |  |  |  |  |
Balance at beginning of period |  | $ | (617) |  |  | $ | (634) |  |  |  |  |
Aggregate adjustment for the period, net of tax |  | 17 |  |  | 55 |  |  |  |  |
Balance at end of period |  | $ | (600) |  |  | $ | (579) |  |  |  |  |
Realized and unrealized gains (losses) on derivatives |  |  |  |  |  |  |  |
Balance at beginning of period |  | $ | (8) |  |  | $ | (28) |  |  |  |  |
Current period changes in fair value, net of tax |  | (1) |  |  | 25 |  |  |  |  |
Reclassification to income, net of tax |  | (1) |  |  | 3 |  |  |  |  |
Balance at end of period |  | $ | (10) |  |  | $ | — |  |  |  |  |
Pension and postretirement plans |  |  |  |  |  |  |  |
Balance at beginning of period |  | $ | (2) |  |  | $ | (3) |  |  |  |  |
Balance at end of period |  | $ | (2) |  |  | $ | (3) |  |  |  |  |
Accumulated other comprehensive income (loss), end of period |  | $ | (612) |  |  | $ | (582) |  |  |  |  |

Adient consolidates certain subsidiaries in which the noncontrolling interest party has within their control the right to require Adient to redeem all or a portion of its interest in the subsidiary. These redeemable noncontrolling interests are reported at their estimated redemption value. Any adjustment to the redemption value impacts retained earnings but does not impact net income. Redeemable noncontrolling interests which are redeemable only upon future events, the occurrence of which is not currently probable, are recorded at carrying value. The following table presents changes in the redeemable noncontrolling interests:

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Beginning balance |  | $ | 240 |  |  | $ | 43 |  |  |  |  |
Net income |  | 13 |  |  | 6 |  |  |  |  |
Dividends |  | (31) |  |  | (14) |  |  |  |  |
Change in redeemable noncontrolling interest |  | (186) |  |  | — |  |  |  |  |
Foreign currency translation adjustments |  | 5 |  |  | 7 |  |  |  |  |
Ending balance |  | $ | 41 |  |  | $ | 42 |  |  |  |  |

Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information on the change in redeemable noncontrolling interest during the three months ended December 31, 2021.

12. Retirement Plans

Adient maintains non-contributory defined benefit pension plans covering primarily non-U.S. employees and a limited number of U.S. employees. The following table contains the components of net periodic benefit cost:
Adient plc | Form 10-Q | 22

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Service cost |  | $ | 2 |  |  | $ | 2 |  |  |  |  |
Interest cost |  | 3 |  |  | 2 |  |  |  |  |
Expected return on plan assets |  | (4) |  |  | (4) |  |  |  |  |
Net periodic benefit cost |  | $ | 1 |  |  | $ | — |  |  |  |  |

The interest cost and expected return on plan assets components of net periodic benefit cost are included in other pension expense (income) in the consolidated statements of income (loss).

13. Restructuring and Impairment Costs

To better align its resources with its overall strategies and reduce the cost structure of its global operations to address the softness in certain underlying markets, Adient commits to restructuring plans as necessary.
During the first quarter of fiscal 2022, Adient committed to a restructuring plan ("2022 Plan") of $3 million that was offset by $6 million of prior year underspend. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA and Americas. The restructuring actions are expected to be substantially completed within fiscal 2022.

(in millions) |  | Employee Severance and Termination Benefits |  |  |  |  |  |  |  | Total
Original reserve |  | $ | 3 |  |  |  |  |  |  |  |  | $ | 3 |
Utilized—cash |  | (1) |  |  |  |  |  |  |  |  | (1) |
Balance at December 31, 2021 |  | $ | 2 |  |  |  |  |  |  |  |  | $ | 2 |

During fiscal 2021, Adient committed to a restructuring plan ("2021 Plan") of $27 million that was offset by $16 million of prior year underspend. Of the restructuring costs recorded, $23 million related to the EMEA segment, $3 million related to the Americas segment, and $1 million related to the Asia segment. The restructuring actions related to cost reduction initiatives and consisted primarily of workforce reductions and lease contract terminations. The restructuring actions are expected to be substantially completed by fiscal 2023.

(in millions) |  | Employee Severance and Termination Benefits |  |  |  |  |  |  |  | Total
Balance at September 30, 2021 |  | $ | 22 |  |  |  |  |  |  |  |  | $ | 22 |
Utilized—cash |  | (10) |  |  |  |  |  |  |  |  | (10) |
Noncash adjustment—other |  | (1) |  |  |  |  |  |  |  |  | (1) |
Balance at December 31, 2021 |  | $ | 11 |  |  |  |  |  |  |  |  | $ | 11 |

During fiscal 2020, Adient committed to a restructuring plan ("2020 Plan") of $205 million. Of the restructuring costs recorded, $20 million related to the Americas segment, $175 million related to the EMEA segment and $10 million related to the Asia segment. The restructuring actions related to cost reduction initiatives and consist primarily of workforce reductions. Also recorded in fiscal 2020 was $20 million of underspend related to prior year plan reserves. The restructuring actions are expected to be substantially completed by fiscal 2022.
Adient plc | Form 10-Q | 23

The following table summarizes the changes in Adient's 2020 Plan reserve:

(in millions) |  | Employee Severance and Termination Benefits |  |  |  |  |  | Currency Translation |  | Total
Balance at September 30, 2021 |  | $ | 75 |  |  |  |  |  |  | $ | 2 |  |  | $ | 77 |
Utilized—cash |  | (10) |  |  |  |  |  |  | — |  |  | (10) |
Noncash adjustment—underspend/other |  | (5) |  |  |  |  |  |  | (1) |  |  | (6) |
Balance at December 31, 2021 |  | $ | 60 |  |  |  |  |  |  | $ | 1 |  |  | $ | 61 |

The following table summarizes the changes in Adient's 2019 Plan reserve:

(in millions) |  | Employee Severance and Termination Benefits |  |  |  | Currency Translation |  | Total
Balance at September 30, 2021 |  | $ | 8 |  |  |  |  | $ | 1 |  |  | $ | 9 |
Utilized—cash |  | (2) |  |  |  |  | — |  |  | (2) |
Noncash adjustment—underspend/other |  | (1) |  |  |  |  | — |  |  | (1) |
Balance at December 31, 2021 |  | $ | 5 |  |  |  |  | $ | 1 |  |  | $ | 6 |

During the first three months of fiscal 2022, there was $1 million of cash utilized against the 2018, 2017 and 2016 Plan's reserve balances. The majority of the cash utilized during the period was related to the 2016 Plan's reserve balance. The 2018, 2017, and 2016 Plan's reserve balances at December 31, 2021 were $3 million, $2 million, and $1 million, respectively.
Adient's restructuring plans include workforce reductions of approximately 15,000 employees. Restructuring charges associated with employee severance and termination benefits are paid over the severance period granted to each employee or on a lump sum basis in accordance with individual severance agreements. As of December 31, 2021, approximately 14,000 of the employees have been separated from Adient pursuant to the restructuring plans. In addition, the restructuring plans included twenty-five plant closures. As of December 31, 2021, twenty of the twenty-five plants have been closed.
Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Because of the importance of new vehicle sales by major automotive manufacturers to operations, Adient is affected by the general business conditions in the automotive industry. Future adverse developments in the automotive industry, particularly related to the COVID-19 pandemic and supply chain disruptions, could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

14. Income Taxes

In calculating the provision for income taxes, Adient uses an estimate of the annual effective tax rate based upon the facts and circumstances known at each interim period. On a quarterly basis, the actual effective tax rate is adjusted, as appropriate, based on changes in facts and circumstances, if any, as compared to those forecasted at the beginning of the fiscal year and each interim period thereafter. For the three months ended December 31, 2021, Adient’s income tax expense was $21 million equating to an effective tax rate of (233)%. The three month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances and foreign tax rate differentials. For the three months ended December 31, 2020, Adient’s income tax expense was $52 million equating to an effective tax rate of 23%. The income tax expense was higher than the statutory rate of 12.5% primarily due to foreign tax rate differentials and the inability to record a tax benefit for losses in jurisdictions with valuation allowances.
Adient plc | Form 10-Q | 24

Valuation Allowances
As a result of the Company's first quarter fiscal 2022 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined that no changes to valuation allowances were required.
Adient reviews the realizability of its deferred tax assets on a quarterly basis, or whenever events or changes in circumstances indicate that a review is required. In determining the requirement for a valuation allowance, the historical and projected financial results of the legal entity or combined group recording the net deferred tax asset are considered, along with any other positive or negative evidence. All of the factors that Adient considers in evaluating whether and when to establish or release all or a portion of the deferred tax asset valuation allowance involve significant judgment. Since future financial results may differ from previous estimates, periodic adjustments to Adient's valuation allowances may be necessary.
Uncertain Tax Positions
At December 31, 2021, Adient had gross tax effected unrecognized tax benefits of $490 million. If recognized, $128 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at December 31, 2021 was approximately $20 million (net of tax benefit). The interest and penalties accrued for the three months ended December 31, 2021 was $2 million. Adient recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Impacts of Tax Legislation and Change in Statutory Tax Rates
Tax legislation was adopted during the three months ended December 31, 2021 in various jurisdictions, which did not have a material impact on Adient’s consolidated financial statements.
Other Tax Matters
During the first quarter of fiscal 2022, Adient recognized a $3 million tax benefit related to the write-off of deferred tax liabilities on Brazil indirect tax credits as a result of a favorable court ruling.
During the first quarter of fiscal 2021, Adient recognized an $8 million pre-tax gain related to Brazil indirect tax recoveries. The tax expense associated with this gain was $3 million

15. Segment Information

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").
Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.
Adient plc | Form 10-Q | 25

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Net Sales |  |  |  |  |  |  |  |
Americas |  | $ | 1,498 |  |  | $ | 1,737 |  |  |  |  |
EMEA |  | 1,230 |  |  | 1,604 |  |  |  |  |
Asia |  | 784 |  |  | 554 |  |  |  |  |
Eliminations |  | (32) |  |  | (47) |  |  |  |  |
Total net sales |  | $ | 3,480 |  |  | $ | 3,848 |  |  |  |  |

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Adjusted EBITDA |  |  |  |  |  |  |  |
Americas |  | $ | 9 |  |  | $ | 132 |  |  |  |  |
EMEA |  | 43 |  |  | 114 |  |  |  |  |
Asia |  | 114 |  |  | 151 |  |  |  |  |
Corporate-related costs (1) |  | (20) |  |  | (19) |  |  |  |  |
Restructuring and impairment costs (2) |  | (4) |  |  | (7) |  |  |  |  |
Purchase accounting amortization (3) |  | (14) |  |  | (11) |  |  |  |  |
Restructuring related charges (4) |  | (1) |  |  | (4) |  |  |  |  |
Depreciation |  | (75) |  |  | (70) |  |  |  |  |
Stock based compensation |  | (10) |  |  | (13) |  |  |  |  |
Other items (5) |  | (2) |  |  | 9 |  |  |  |  |
Earnings (loss) before interest and income taxes |  | 40 |  |  | 282 |  |  |  |  |
Net financing charges |  | (50) |  |  | (59) |  |  |  |  |
Other pension income (expense) |  | 1 |  |  | 2 |  |  |  |  |
Income (loss) before income taxes |  | $ | (9) |  |  | $ | 225 |  |  |  |  |

Notes:
(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.
(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 and non-recurring impairment charges. During the three months ended December 31, 2021 and 2020, a held-for-sale impairment charge of $7 million and $6 million, respectively, was recorded in EMEA.
(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.
(4) Reflects restructuring related charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420.
(5) The three months ended December 31, 2021 reflects $2 million of transaction costs. The three months ended December 31, 2020 reflects a one-time gain of $8 million associated with retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling, a $5 million gain on previously held interest at YFAS in an affiliate, and $4 million of transaction costs.
Adient plc | Form 10-Q | 26

Geographic Information
Revenue by geographic area is as follows:

Net Sales |  |  |  |  |  |  |  |
|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Americas |  |  |  |  |  |  |  |
United States |  | $ | 1,331 |  |  | $ | 1,548 |  |  |  |  |
Mexico |  | 541 |  |  | 641 |  |  |  |  |
Other Americas |  | 91 |  |  | 92 |  |  |  |  |
Regional elimination |  | (465) |  |  | (544) |  |  |  |  |
|  | 1,498 |  |  | 1,737 |  |  |  |  |
EMEA |  |  |  |  |  |  |  |
Germany |  | 233 |  |  | 314 |  |  |  |  |
Czech Republic |  | 267 |  |  | 338 |  |  |  |  |
Other EMEA |  | 1,039 |  |  | 1,385 |  |  |  |  |
Regional elimination |  | (309) |  |  | (433) |  |  |  |  |
|  | 1,230 |  |  | 1,604 |  |  |  |  |
Asia |  |  |  |  |  |  |  |
Thailand |  | 135 |  |  | 105 |  |  |  |  |
China |  | 414 |  |  | 189 |  |  |  |  |
Japan |  | 35 |  |  | 89 |  |  |  |  |
Other Asia |  | 206 |  |  | 177 |  |  |  |  |
Regional elimination |  | (6) |  |  | (6) |  |  |  |  |
|  | 784 |  |  | 554 |  |  |  |  |
Inter-segment elimination |  | (32) |  |  | (47) |  |  |  |  |
Total |  | $ | 3,480 |  |  | $ | 3,848 |  |  |  |  |

The increase in net sales in China is attributable to the consolidation of CQADNT beginning October 1, 2021. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.

16. Nonconsolidated Partially-Owned Affiliates

Investments in the net assets of nonconsolidated partially-owned affiliates are reported in the "Investments in partially-owned affiliates" line in the consolidated statements of financial position as of December 31, 2021 and September 30, 2021. Equity in the net income of nonconsolidated partially-owned affiliates are reported in the "Equity income (loss)" line in the consolidated statements of income (loss) for the three months ended December 31, 2021 and 2020, respectively.
Adient plc | Form 10-Q | 27

Adient maintains total investments in partially-owned affiliates of $367 million and $335 million at December 31, 2021 and September 30, 2021, respectively. Operating information for nonconsolidated partially-owned affiliates is as follows:

|  | Three Months Ended December 31,
(in millions) |  | 2021 |  | 2020
Income statement data: |  |  |  |
Net sales |  | $ | 1,208 |  |  | $ | 2,625 |
Gross profit |  | $ | 127 |  |  | $ | 319 |
Net income |  | $ | 67 |  |  | $ | 211 |
Net income attributable to the entity |  | $ | 67 |  |  | $ | 210 |

Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for the divestiture transactions involving Adient's investments in nonconsolidated partially-owned affiliates during fiscal 2021.

17. Commitments and Contingencies

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, casualty environmental, safety and health, intellectual property, employment, commercial and contractual matters, and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Costs related to such matters were not material to the periods presented.
Adient accrues for potential environmental liabilities when it is probable a liability has been incurred and the amount of the liability is reasonably estimable. Reserves for environmental liabilities totaled $8 million and $8 million at December 31, 2021 and September 30, 2021, respectively. Adient reviews the status of its environmental sites on a quarterly basis and adjusts its reserves accordingly. Such potential liabilities accrued by Adient do not take into consideration possible recoveries of future insurance proceeds. They do, however, take into account the likely share other parties will bear at remediation sites. It is difficult to estimate Adient's ultimate level of liability at many remediation sites due to the large number of other parties that may be involved, the complexity of determining the relative liability among those parties, the uncertainty as to the nature and scope of the investigations and remediation to be conducted, the uncertainty in the application of law and risk assessment, the various choices and costs associated with diverse technologies that may be used in corrective actions at the sites, and the often quite lengthy periods over which eventual remediation may occur. Nevertheless, Adient does not currently believe that any claims, penalties or costs in connection with known environmental matters will have a material adverse effect on Adient's financial position, results of operations or cash flows.
Adient plc | Form 10-Q | 28

18. Related Party Transactions

In the ordinary course of business, Adient enters into transactions with related parties, such as equity affiliates. Such transactions consist of the sale or purchase of goods and other arrangements.
The following table sets forth the net sales to and purchases from related parties included in the consolidated statements of income:

|  |  |  | Three Months Ended December 31, |  |
(in millions) |  |  |  | 2021 |  | 2020 |  |  |  |
Net sales to related parties |  | Net sales |  | $ | 56 |  |  | $ | 70 |  |  |  |  |
Purchases from related parties |  | Cost of sales |  | 96 |  |  | 146 |  |  |  |  |

The following table sets forth the amount of accounts receivable due from and payable to related parties in the consolidated statements of financial position:

(in millions) |  |  |  | December 31, 2021 |  | September 30, 2021
Accounts receivable due from related parties |  | Accounts receivable |  | $ | 29 |  |  | $ | 30 |
Accounts payable due to related parties |  | Accounts payable |  | 32 |  |  | 41 |

Average receivable and payable balances with related parties remained consistent with the period end balances shown above.
Adient plc | Form 10-Q | 29

Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements
This section and other parts of this Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "can," "may," or similar terms. Forward-looking statements are not guarantees of future performance and Adient's actual results may differ significantly from the results discussed in the forward-looking statements. Adient cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Adient’s control, that could cause Adient’s actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, risks related to: whether recently completed strategic transactions in China and deleveraging activities may yield additional value for shareholders at all or on the same or different terms as those described herein, the timing, benefits and outcomes of the strategic transactions in China and / or the activities relating to our capital structure, the effects of local and national economic, credit and capital market conditions on the economy in general, and other risks and uncertainties, the continued financial and operational impacts of and uncertainties relating to the COVID-19 pandemic on Adient and its customers, suppliers, joint venture partners and other parties, the ability of Adient to execute its turnaround plan, work stoppages, including due to supply chain disruptions and similar events, energy and commodity (particularly steel) prices, the availability of raw materials (including petrochemicals) and component products (including components required by our customers for the manufacture of vehicles (i.e., semiconductor chips)), automotive vehicle production levels, mix and schedules, as well as our concentration of exposure to certain automotive manufacturers, the ability of Adient to effectively launch new business at forecast and profitable levels, the ability of Adient to meet debt service requirements, the terms of future financing, the impact of tax reform legislation, uncertainties in U.S. administrative policy regarding trade agreements, tariffs and other international trade relations, general economic and business conditions, the strength of the U.S. or other economies, shifts in market shares among vehicles, vehicle segments or away from vehicles on which Adient has significant content, changes in consumer demand, global climate change and related emphasis on ESG matters by various stakeholders, currency exchange rates and cancellation of or changes to commercial arrangements, and the ability of Adient to identify, recruit and retain key leadership. Additional information regarding these and other risks related to Adient’s business that could cause actual results to differ materially from what is contained in the forward-looking statements is included in the section entitled "Risk Factors," contained in Item Part II, Other Information - Item 1A of this report, as well as in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included within this report as well as within Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. All information presented herein is based on Adient's fiscal calendar. Unless otherwise stated, references to particular years, quarters, months or periods refer to Adient's fiscal years ended in September and the associated quarters, months and periods of those fiscal years. Adient assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Overview
Adient is a global leader in the automotive seating supply industry with leading market positions in the Americas, Europe and China and maintains longstanding relationships with the largest global automotive original equipment manufacturers (OEMs). Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is a global seat supplier with the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world.
Adient designs, manufactures and markets a full range of seating systems and components for passenger cars, commercial vehicles and light trucks, including vans, pick-up trucks and sport/crossover utility vehicles. Adient operates in 202 wholly- and majority-owned manufacturing or assembly facilities, with operations in 32 countries. Additionally, Adient has partially-owned affiliates in China, Asia, Europe and North America. Through its global footprint, vertical integration and partnerships in China, Adient leverages its capabilities to drive growth in the automotive seating industry.
Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").
Adient plc | Form 10-Q | 30

Supply Chain Disruptions and Inflationary Pressures
The global automotive industry continues to experience widespread supply chain disruptions primarily related to semiconductor chip shortages. Although Adient’s seating products are not highly dependent on semiconductor chips, Adient is directly impacted by the lower production levels at the OEMs as a result of these supply disruptions. These disruptions have led to unplanned downtime at Adient’s production facilities, often with very little warning, which results in operating inefficiencies and limits Adient’s ability to adequately mitigate such inefficiencies. The automotive industry has also experienced a period of sustained price increases for commodities, primarily related to steel, and to a lesser extent petrochemicals. Modestly softer steel pricing began to occur in the first quarter of fiscal 2022, but are still higher than historical averages. Shipping costs have also sharply increased throughout fiscal 2021 and remained above historical norms during the first quarter of fiscal 2022. These commodity and shipping cost increases may continue into the future as demand increases and supply may remain constrained, which has resulted in, and may continue to result in, increased costs for Adient that may not be, or may only be partially, offset. Adient is also closely monitoring labor availability and wage inflationary pressures, both internally and at key vendors, to assess any impact labor shortages and wage inflation might have on Adient’s ability to perform its obligations. Although Adient has developed and implemented strategies to mitigate the impact of higher raw material, commodity and shipping costs, these strategies (which include targeted SG&A savings through hiring freezes, delayed merit increases, suspended 401(k) matches in the U.S. and RSU replacement awards in lieu of salary for certain executives of Adient), together with commercial negotiations with Adient's customers and suppliers, are only expected to offset a portion of the adverse impact. Refer to the consolidated results of operations and segment analysis discussion below for additional information on the impacts of these items on Adient's results.
On-Going Impact of COVID-19
The impact of COVID-19, and related mutations including the Omicron variant, continues to be present throughout the world, including in all global and regional markets served by Adient. Although vaccines have been introduced that are expected to have the result of reducing the effect of COVID-19 and COVID-19 started to wane in certain geographic areas, governmental authorities continue to implement numerous measures attempting to contain and mitigate the effects of COVID-19, including travel bans and restrictions, quarantines, social distancing orders, shelter in place orders and shutdowns of non-essential activities. Adient's manufacturing facilities are located in areas that continue to be affected by the pandemic.
Although the global automotive industry experienced increased demand for new vehicles as Adient emerged from the global shutdowns in late fiscal year 2020 and early fiscal year 2021, it is possible that, in the event of the resurgence of COVID-19, the global automotive industry will experience significantly lower demand for new vehicle sales over the long-term as a result of the global economic slowdown caused by the COVID-19 pandemic because new vehicle sales are highly dependent on strong consumer confidence and low unemployment. As a result, new vehicle sales could be significantly lower than historical and previously projected pre-pandemic sales levels.
Throughout fiscal years 2020 and 2021 and into fiscal year 2022, Adient continues to actively monitor the threat and impacts of COVID-19. Adient has taken, and continues to take, steps to mitigate the potential risks to the Company posed by COVID-19 and its impacts. In addition, Adient continues to assess and update its business continuity plans in the context of this pandemic, including analyzing constraints at its customers and suppliers, particularly components and labor-related shortages, respectively. Adient has taken precautions to help keep its workforce healthy and safe, including establishing a Global Response Team, implementing strict travel restrictions, enforcing rigorous hygiene protocols, increasing sanitization efforts at all facilities, enacting visitor restrictions, social distancing, face covering expectations, and temperature and health screenings and implementing remote working arrangements for the vast majority of Adient's employees who work outside the plants.
The spread of COVID-19 and the measures taken to restrain the spread of the virus have had, and may continue to have, a material negative impact on Adient's financial results and liquidity, and such negative impact may continue well beyond the containment of COVID-19 through the results of widespread use of the vaccine or otherwise. Adient cannot assure that the assumptions used to estimate its liquidity requirements will be correct because it has never previously experienced such a widespread cessation of its operations as it experienced during fiscal year 2020, and it is unclear what the lasting impacts of the slowdown in the automotive industry will be. In addition, the magnitude, duration, speed and potential resurgence or surges of the global pandemic are all uncertain. Consequently, the impact of the pandemic and its myriad of effects on Adient's business, financial condition or longer-term financial or operational results remain uncertain. Based on the actions it has taken and its current assumptions regarding the impact of COVID-19, Adient believes that its current financial resources will be sufficient to fund the company's liquidity requirements for at least the next twelve months.
Global Automotive Industry
Adient plc | Form 10-Q | 31

Adient conducts its business globally in the automotive industry, which is highly competitive and sensitive to economic, political and social factors in the various regions. During fiscal 2021, automotive production across the globe declined due to the economic slow down resulting from the COVID-19 pandemic and the widespread supply chain disruptions primarily due to semiconductor chip shortages. During the first quarter of fiscal 2022, global light vehicle production decreased 13.1% year over year as a result of on-going global semiconductor chip shortages. Unplanned production stoppages by customers resulted in lower sales as well as higher operational costs and other surcharges at Adient. The challenging operational environment is expected to continue well into fiscal 2022.
Light vehicle production levels by geographic region are provided below:

|  | Light Vehicle Production
|  | Three Months Ended December 31, |  |
(units in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Global |  | 20.5 |  |  | (13.2)% |  | 23.6 |  |  |  |  |  |  |
North America |  | 3.3 |  |  | (14.7)% |  | 3.9 |  |  |  |  |  |  |
South America |  | 0.7 |  |  | (7.7)% |  | 0.8 |  |  |  |  |  |  |
EMEA |  | 4.4 |  |  | (24.0)% |  | 5.8 |  |  |  |  |  |  |
China |  | 7.4 |  |  | (5.6)% |  | 7.8 |  |  |  |  |  |  |
Asia, excluding China, and Other |  | 4.7 |  |  | (12.4)% |  | 5.4 |  |  |  |  |  |  |
Source: IHS Automotive, January 2022 |  |  |  |  |  |  |  |  |  |

Financial Results Summary
Significant aspects of Adient's financial results for the first quarter of fiscal 2022 include the following:
•Adient recorded net sales of $3,480 million for the first quarter of fiscal 2022, representing a decrease of $368 million or 10% when compared to the first quarter of fiscal 2021. The decrease in net sales is attributable to temporary operational interruptions and production stoppages primarily resulting from semiconductor chip shortages and supply chain issues, the unfavorable impact of foreign currencies, and unfavorable commercial settlements, partially offset by favorable material economics recoveries and operational footprint changes primarily including the consolidation of CQADNT in China.
•Gross profit was $173 million, or 5.0% of net sales for the first quarter of fiscal 2022 compared to $341 million, or 8.9% of net sales for the first quarter of fiscal 2021. Profitability, including gross profit as a percentage of net sales, was lower due to lower production volume as described above and related operational inefficiencies including higher premium freight, unfavorable impacts of material economics, net of recoveries, and unfavorable commercial settlements, net of favorable supplier settlements, partially offset by operational footprint changes including those in China as described the net sales discussion above.
•Equity income was $33 million for the first quarter of fiscal 2022, compared to $97 million for the first quarter of fiscal 2021. The decrease is primarily attributable to prior year divestitures of Adient's interests in YFAS, SJA, and GZDFAS as well as the acquisition of controlling interest in CQADNT, and operational interruptions and production stoppages resulting from semiconductor chip shortages primarily at Adient's affiliates, partially offset by the favorable impact of foreign currencies.
•Net loss attributable to Adient was $54 million for the first quarter of fiscal 2022, compared to $150 million of net income attributable to Adient for the first quarter of fiscal 2021. The net loss in the first quarter of fiscal 2022 is primarily attributable to lower production volume primarily resulting from semiconductor chip shortages and supply chain issues as described above and related operational inefficiencies including higher premium freight, lower equity income resulting from prior year divestitures of certain affiliates in China as described above, lower levels of material economics recoveries, unfavorable commercial settlements, higher depreciation and amortization expense, and higher overall selling, general and administrative expense, partially offset by lower restructuring charges, lower net financing charges, and the favorable impact of operational footprint changes primarily including the consolidation of CQADNT in China.
Adient plc | Form 10-Q | 32

Consolidated Results of Operations

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Net sales |  | $ | 3,480 |  |  | (10)% |  | $ | 3,848 |  |  |  |  |  |  |
Cost of sales |  | 3,307 |  |  | (6)% |  | 3,507 |  |  |  |  |  |  |
Gross profit |  | 173 |  |  | (49)% |  | 341 |  |  |  |  |  |  |
Selling, general and administrative expenses |  | 162 |  |  | 9% |  | 149 |  |  |  |  |  |  |
Restructuring and impairment costs |  | 4 |  |  | (43)% |  | 7 |  |  |  |  |  |  |
Equity income (loss) |  | 33 |  |  | (66)% |  | 97 |  |  |  |  |  |  |
Earnings (loss) before interest and income taxes |  | 40 |  |  | (86)% |  | 282 |  |  |  |  |  |  |
Net financing charges |  | 50 |  |  | (15)% |  | 59 |  |  |  |  |  |  |
Other pension expense (income) |  | (1) |  |  | 50% |  | (2) |  |  |  |  |  |  |
Income (loss) before income taxes |  | (9) |  |  | >(100%) |  | 225 |  |  |  |  |  |  |
Income tax provision (benefit) |  | 21 |  |  | (60)% |  | 52 |  |  |  |  |  |  |
Net income (loss) |  | (30) |  |  | >(100%) |  | 173 |  |  |  |  |  |  |
Income (loss) attributable to noncontrolling interests |  | 24 |  |  | 4% |  | 23 |  |  |  |  |  |  |
Net income (loss) attributable to Adient |  | $ | (54) |  |  | >(100%) |  | $ | 150 |  |  |  |  |  |  |

Net Sales

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Net sales |  | $ | 3,480 |  |  | (10)% |  | $ | 3,848 |  |  |  |  |  |  |

Net sales decreased by $368 million, or 10%, in the first quarter of fiscal 2022 as compared to the first quarter of fiscal 2021 due to unplanned temporary production stoppages primarily resulting from semiconductor chip shortages and supply chain issues, ($462 million), the unfavorable impact of foreign currencies ($73 million), and lower levels of commercial settlements year over year ($26 million), partially offset by favorable material economics recoveries ($66 million) and operational footprint changes primarily including the consolidation of CQADNT in China ($127 million).
Cost of Sales / Gross Profit

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Cost of sales |  | $ | 3,307 |  | (6)% |  | $ | 3,507 |  |  |  |  |  |
Gross profit |  | $ | 173 |  | (49)% |  | $ | 341 |  |  |  |  |  |
% of sales |  | 5.0 | % |  |  |  | 8.9 | % |  |  |  |  |  |

Cost of sales decreased by $200 million, or 6%, and gross profit decreased by $168 million in the first quarter of fiscal 2022 as compared to the first quarter of fiscal 2021. The year over year decrease in cost of sales was due to lower volumes primarily resulting from the semiconductor chip shortages and supply chain issues as noted above ($360 million), the favorable impact of foreign currencies ($69 million), and favorable supplier settlements ($12 million), partially offset by operational footprint changes primarily including the consolidation of CQADNT in China ($114 million), higher commodity costs ($69 million), operational inefficiencies including higher premium freight primarily resulting from unplanned production stoppages ($47 million), higher depreciation expense ($5 million), and prior year non-recurring favorable items ($8 million). Gross profit was unfavorably impacted by lower overall volumes, the unfavorable impact of foreign currencies, higher commodity costs, and inefficiencies caused by unplanned production stoppages. Refer to the segment analysis below for a discussion of segment profitability.
Adient plc | Form 10-Q | 33

Selling, General and Administrative Expenses

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Selling, general and administrative expenses |  | $ | 162 |  | 9% |  | $ | 149 |  |  |  |  |  |
% of sales |  | 4.7% |  |  |  | 3.9% |  |  |  |  |  |

Selling, general and administrative expenses (SG&A) increased by $13 million, or 9% in the first quarter of fiscal 2022 as compared to the first quarter of fiscal 2021. The year over year increase in SG&A is attributable to higher overall engineering and other administrative spending attributable to adverse events during the first quarter of fiscal 2022 (primarily the Malaysia flooding event and certain legal settlements) and certain one-time benefits in prior year ($14 million), higher amortization expense attributable to the acquired intangible assets ($3 million), and the prior year acquisitions and consolidations of CQADNT and LFADNT ($7 million), partially offset by lower compensation expense including stock-based and performance-based incentive compensation costs ($7 million), and lower transaction costs ($2 million).
Restructuring and Impairment Costs

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Restructuring and impairment costs |  | $ | 4 |  |  | (43)% |  | $ | 7 |  |  |  |  |  |  |

Restructuring and impairment costs were lower by $3 million during the first quarter of fiscal 2022 due primarily to overall lower levels of restructuring actions taken. Refer to Note 3, "Acquisitions and Divestitures," and Note 13, "Restructuring and Impairment Costs," of the notes to the consolidated financial statements for information related to Adient's restructuring plans.
Equity Income (Loss)

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Equity income (loss) |  | $ | 33 |  |  | (66)% |  | $ | 97 |  |  |  |  |  |  |

Equity income was $33 million for the first quarter of fiscal 2022, compared to $97 million in the first quarter of fiscal 2021. The decrease is primarily attributable to prior year divestitures of Adient's interests in YFAS, GZDFAS and SJA, as well as acquisition of controlling interest in CQADNT ($58 million), operational interruptions and production stoppages resulting from semiconductor chip shortages primarily at Adient's affiliates ($5 million), and higher restructuring charges primarily at Adient's affiliates in China ($4 million), partially offset by the favorable impact of foreign currencies ($3 million).
Net Financing Charges

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Net financing charges |  | $ | 50 |  |  | (15)% |  | $ | 59 |  |  |  |  |  |  |

Net financing charges decreased in the first quarter of fiscal 2022 as compared to the first quarter of fiscal 2021 primarily as a result of lower levels of outstanding debt, partially offset by the $3 million derivative loss related to the 2021 Yanfeng Transaction. Refer to Note 8, "Debt and Financing Arrangements," of the notes to the consolidated financial statements for further information related to Adient's debt transactions during the current quarter and components of the net financing charges.
Adient plc | Form 10-Q | 34

Other Pension Expense (Income)

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Other pension expense (income) |  | $ | (1) |  |  | 50% |  | $ | (2) |  |  |  |  |  |  |

Other pension income remained fairly consistent year over year. Refer to Note 12, "Retirement Plans," of the notes to the consolidated financial statements for information related to the non-service components of Adient's net periodic pension costs.
Income Tax Provision

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Income tax provision (benefit) |  | $ | 21 |  |  | (60)% |  | $ | 52 |  |  |  |  |  |  |

The first quarter of fiscal 2022 income tax expense of $21 million was higher than the statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances and foreign tax rate differentials. The first quarter of fiscal 2021 income tax expense of $52 million was higher than the statutory rate of 12.5% primarily due to foreign tax rate differentials, the inability to record a tax benefit for losses in jurisdictions with valuation allowances, and the additional expense resulting from the $8 million pre-tax gain associated with the indirect tax recoveries in Brazil.
Income Attributable to Noncontrolling Interests

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Income (loss) attributable to noncontrolling interests |  | $ | 24 |  |  | 4% |  | $ | 23 |  |  |  |  |  |  |

The $1 million increase in income attributable to noncontrolling interests for the three months ended December 31, 2021 when compared to the same period in the prior year was primarily attributable to the prior year acquisition of controlling interest in CQADNT, partially offset by lower income resulting from lower volumes in the current year, attributable primarily to the unplanned production stoppages and operational interruptions at certain Seating affiliates in varying jurisdictions.
Net Income (Loss) Attributable to Adient

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Net income (loss) attributable to Adient |  | $ | (54) |  |  | >(100%) |  | $ | 150 |  |  |  |  |  |  |

Net loss attributable to Adient was $54 million for the first quarter of fiscal 2022, compared to $150 million of net income attributable to Adient for the first quarter of fiscal 2021. The loss in the first quarter of fiscal 2022 is primarily attributable to unplanned temporary production stoppages primarily resulting from semiconductor chip shortages and supply chain issues, lower equity income attributable to prior year divestitures of Adient's interests in YFAS and SJA, higher overall selling, general and administrative expense, partially offset by lower net financing charges and income tax expense.
Comprehensive Income (Loss) Attributable to Adient

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Comprehensive income (loss) attributable to Adient |  | $ | (39) |  |  | >-100% |  | $ | 233 |  |  |  |  |  |  |

Adient plc | Form 10-Q | 35

Comprehensive loss attributable to Adient was $39 million for the first quarter of fiscal 2022 compared to $233 million of comprehensive income for the first quarter of fiscal 2021. The current quarter comprehensive loss attributable to Adient is primarily due to net loss of $30 million. The comprehensive income attributable to noncontrolling interest was unfavorably impacted during the first quarter of fiscal 2022 due to the consolidation of CQADNT beginning October 1, 2021. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.
Segment Analysis
Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").
Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, qualified restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.
The results presented below are not necessarily indicative of full-year results, particularly due to the on-going impacts of higher commodity costs, inefficiencies caused by unplanned production stoppages, and the COVID-19 pandemic that Adient is currently facing. Refer to the Supply Chain Disruptions and Inflationary Pressures and On-Going Impact of COVID-19 sections earlier in Item 2. of this Report and our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, for additional information related to the impacts on Adient.
Financial information relating to Adient's reportable segments is as follows:

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Net Sales |  |  |  |  |  |  |  |
Americas |  | $ | 1,498 |  |  | $ | 1,737 |  |  |  |  |
EMEA |  | 1,230 |  |  | 1,604 |  |  |  |  |
Asia |  | 784 |  |  | 554 |  |  |  |  |
Eliminations |  | (32) |  |  | (47) |  |  |  |  |
Total net sales |  | $ | 3,480 |  |  | $ | 3,848 |  |  |  |  |

Adient plc | Form 10-Q | 36

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | 2020 |  |  |  |
Adjusted EBITDA |  |  |  |  |  |  |  |
Americas |  | $ | 9 |  |  | $ | 132 |  |  |  |  |
EMEA |  | 43 |  |  | 114 |  |  |  |  |
Asia |  | 114 |  |  | 151 |  |  |  |  |
Corporate-related costs (1) |  | (20) |  |  | (19) |  |  |  |  |
Restructuring and impairment costs (2) |  | (4) |  |  | (7) |  |  |  |  |
Purchase accounting amortization (3) |  | (14) |  |  | (11) |  |  |  |  |
Restructuring related charges (4) |  | (1) |  |  | (4) |  |  |  |  |
Depreciation |  | (75) |  |  | (70) |  |  |  |  |
Stock based compensation |  | (10) |  |  | (13) |  |  |  |  |
Other items (5) |  | (2) |  |  | 9 |  |  |  |  |
Earnings (loss) before interest and income taxes |  | 40 |  |  | 282 |  |  |  |  |
Net financing charges |  | (50) |  |  | (59) |  |  |  |  |
Other pension income (expense) |  | 1 |  |  | 2 |  |  |  |  |
Income (loss) before income taxes |  | $ | (9) |  |  | $ | 225 |  |  |  |  |

Notes:
(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.
(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 and non-recurring impairment charges. During the three months ended December 31, 2021 and 2020, a held-for-sale impairment charge of $7 million and $6 million, respectively, was recorded in EMEA.
(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.
(4) Reflects restructuring related charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420.
(5) The three months ended December 31, 2021 reflects $2 million of transaction costs. The three months ended December 31, 2020 reflects a one-time gain of $8 million associated with retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling, a $5 million gain on previously held interest at YFAS in an affiliate, and $4 million of transaction costs.
Americas

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Net sales |  | $ | 1,498 |  |  | (14)% |  | $ | 1,737 |  |  |  |  |  |  |
Adjusted EBITDA |  | $ | 9 |  |  | (93)% |  | $ | 132 |  |  |  |  |  |  |

Net sales decreased during the first quarter of fiscal 2022 by $239 million primarily as a result of operational interruptions due to certain unplanned temporary production stoppages primarily resulting from semiconductor chip shortages and supply chain issues ($224 million), the impact of operational footprint changes ($20 million), the impact of unfavorable commercial settlements and net pricing adjustments ($37 million) and the unfavorable impact of foreign currencies ($3 million), partially offset by the favorable impact of material economics recoveries ($45 million).
Adient plc | Form 10-Q | 37

Adjusted EBITDA decreased during the first quarter of fiscal 2022 by $123 million due primarily to lower current quarter production volumes as explained above ($54 million) and related temporary operating inefficiencies and cost premiums ($10 million), lower levels of commercial settlements and net pricing adjustments ($36 million), unfavorable material economics, net of recoveries ($5 million), the unfavorable impact of foreign currencies ($1 million), unfavorable freight and labor economics, and the non-recurrence of certain one-time benefits ($16 million), and the impact of operational footprint changes ($5 million), partially offset by lower administrative and engineering expense ($4 million).
EMEA

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Net sales |  | $ | 1,230 |  |  | (23)% |  | $ | 1,604 |  |  |  |  |  |  |
Adjusted EBITDA |  | $ | 43 |  |  | (62)% |  | $ | 114 |  |  |  |  |  |  |

Net sales decreased during the first quarter of fiscal 2022 by $374 million primarily as a result of operational interruptions due to certain unplanned temporary production stoppages primarily resulting from semiconductor chip shortages and supply chain issues ($307 million), the unfavorable impact of foreign currency ($58 million), and the impact of operational footprint changes ($43 million), partially offset by the favorable impact of material economics recoveries ($17 million) and favorable impact of commercial settlements and net pricing adjustments ($17 million).
Adjusted EBITDA decreased during the first quarter of fiscal 2022 by $71 million due primarily to lower current quarter production volumes as explained above ($62 million) and related temporary operating inefficiencies and cost premiums ($14 million), the impact of operational footprint changes ($10 million), the unfavorable impact of foreign currencies ($2 million), net unfavorable freight and labor economics ($4 million), and lower equity income ($5 million), partially offset by favorable commercial settlements and net pricing adjustments ($18 million), lower administrative and engineering expense ($4 million), and favorable material economics, net of recoveries ($4 million).
Asia

|  | Three Months Ended December 31, |  |
(in millions) |  | 2021 |  | Change |  | 2020 |  |  |  |  |  |
Net sales |  | $ | 784 |  |  | 42% |  | $ | 554 |  |  |  |  |  |  |
Adjusted EBITDA |  | $ | 114 |  |  | -25% |  | $ | 151 |  |  |  |  |  |  |

Net sales increased during the first quarter of fiscal 2022 by $230 million due to the impact of operational footprint changes including those in China where Adient started consolidating CQADNT and LFADNT ($193 million), favorable volume and mix ($56 million), and the favorable impact of material economics recoveries ($4 million), partially offset by the unfavorable impact of foreign currencies ($17 million) and unfavorable impact of commercial settlements and net pricing adjustments ($6 million).
Adjusted EBITDA decreased during the first quarter of fiscal 2022 by $37 million due primarily to operational footprint changes including the impact of the 2021 Yanfeng Transaction ($38 million), the unfavorable impact of material economics, net of recoveries ($2 million), unfavorable freight and labor economics, and launch timing ($9 million), and higher administrative and engineering expense primarily related to the impact of the Malaysia flooding ($7 million), partially offset by favorable volume and mix ($14 million), and favorable commercial settlements and net pricing adjustments which includes $9 million of a non-recurring settlement in China ($5 million).
Liquidity and Capital Resources
Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintains an asset-based revolving credit facility (the “ABL Credit Facility”), which provides for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity. The ABL Credit Facility will mature on May 6, 2024, subject to a springing
Adient plc | Form 10-Q | 38

maturity date 91 days earlier if certain amounts remain outstanding at that time under the Term Loan B Agreement (defined below). Adient will pay a commitment fee of 0.25% to 0.375% on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the ABL Credit Facility then in effect. Subject to certain conditions, the ABL Credit Facility may be expanded by up to $250 million in additional commitments. Loans under the ABL Credit Facility may be denominated, at the option of Adient, in U.S. dollars, Euros, Pounds Sterling or Swedish Kroner. The ABL Credit Agreement is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. On November 24, 2021, Adient entered into an amendment to its ABL Credit Facility (the “ABL Amendment”) to amend certain terms and provisions, including to (i) change the interest rate benchmark rates applicable under the ABL Credit Facility for borrowings denominated in euro, Swedish krona and pounds sterling to EURIBOR, STIBOR, and SONIA, in each case subject to certain adjustments, and (ii) update the provisions in our ABL Credit Facility by which U.S. dollar LIBOR will eventually be replaced with SOFR or another interest rate benchmark, in each case, to reflect the most recent standards and practices used in the industry. Interest is payable on the ABL Credit Facility at a fluctuating rate of interest determined by reference to LIBOR, in the case of amounts outstanding in dollars, EURIBOR, in the case of amounts outstanding in euros, STIBOR, in the case of amounts outstanding in Swedish krona and SONIA, in the case of amounts outstanding in pounds sterling, in each case, plus an applicable margin of 1.50% to 2.00%. As of December 31, 2021, Adient had not drawn down on the ABL Credit Facility and had availability under this facility of $880 million (net of $59 million of letters of credit).
In addition, Adient US and Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintain a term loan credit agreement (the “Term Loan B Agreement”) that initially provided for a 5-year $800 million senior secured term loan facility that was fully drawn on closing. The Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance originally due at final maturity on May 6, 2024. Interest on the Term Loan B Agreement accrues at the Eurodollar rate plus an applicable margin originally equal to 4.25% (with one 0.25% step down based on achievement of a specific secured net leverage level starting with the fiscal quarter ending December 31, 2019). The Term Loan B Agreement also permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions. In April 2021, Adient amended the Term Loan B Agreement ("Amended Agreement") which, among other changes (i) extended the maturity date for loans outstanding to April 8, 2028, (ii) reduced the interest rate margin applicable thereunder by 0.75% to 3.50%, in the case of Eurodollar Rate loans, and 2.50% (in the case of Base Rate loans) (in each case, with one 0.25% step down based on achievement of a specified first lien secured net leverage level starting with the fiscal quarter ending December 31, 2021) and (iii) made certain other negative covenant and mandatory prepayment changes in connection therewith. The amendment also established incremental term loans in an aggregate principal amount of $214 million resulting in total loans outstanding under the Amended Agreement of $1.0 billion. Adient paid $7 million related to the Amended Agreement and wrote off $8 million of previously deferred financing costs as a result of the debt extinguishment during the third quarter of fiscal 2021.
Adient US was also a party to an indenture relating to the issuance of $800 million aggregate principal amount of Senior First Lien Notes. The notes originally mature on May 15, 2026 and bore interest at a rate of 7.00% per annum. Interest on these notes was payable semi-annually in arrears on November 15 and May 15 of each year, commencing on November 15, 2019. During the second quarter of fiscal 2021, Adient repurchased $640 million of the outstanding balance of the Senior First Lien Notes at a price of 107% of the principal plus $17 million of accrued and unpaid interest. As a result, $9 million of previously deferred financing costs was written off to net financing charges. During the third quarter of fiscal 2021, Adient redeemed the $160 million of remaining balance of the Senior First Lien Notes at a price of 103% of the principal plus $4 million of accrued and unpaid interest, and wrote off $3 million of previously deferred financing costs as a result of the debt extinguishment.
The ABL Credit Facility, Term Loan B Agreement and the Senior First Lien Notes due 2026 contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient’s capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient’s and its restricted subsidiaries’ assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.
Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, maintains $900 million aggregate principal amount of 4.875% USD-denominated unsecured notes due 2026. During the fourth quarter of fiscal 2020, Adient redeemed
Adient plc | Form 10-Q | 39

$103 million of face value of these notes, resulting in a remaining balance of $797 million as of September 30, 2020. Adient further redeemed $2 million of the notes during fiscal 2021, resulting in a remaining balance of $795 million as of September 2021. AGH also maintains €1.0 billion aggregate principal amount of 3.50% unsecured notes due 2024. In January 2022, Adient commenced a cash tender offer for up to €177 million of the 3.50% unsecured notes due 2024.
Adient Germany Ltd. & Co. KG, a wholly owned subsidiary of Adient, maintains €135 million in an unsecured term loan from the European Investment Bank ("EIB") due in 2022. The loan bears interest at the 6-month EURIBOR rate plus 158 basis points. Adient is compliant with the net leverage ratio of 4.5x at December 31, 2021 and expects to be compliant during the remainder of the term. During the first quarter of fiscal 2021, Adient repaid $16 million of the EIB loan, triggered in part by the redemption of debt in the prior year. Adient repaid $20 million of the EIB loan in May 2021, triggered by the prior year sale of the fabrics business.
On April 20, 2020, Adient US issued $600 million (net proceeds of $591 million) aggregate principal amount of 9.00% Senior First Lien Notes due 2025. These notes will mature on April 15, 2025, provided that if AGH has not refinanced (or otherwise redeemed) in whole its outstanding 3.50% unsecured notes due 2024 or any refinancing indebtedness thereof that matures earlier than 91 days prior to the maturity date of the Senior First Lien Notes due 2025 on or prior to May 15, 2024, these notes will mature on May 15, 2024. Interest on these notes is due on April 15 and October 15 each year, beginning on October 15, 2020. These notes contain covenants that are usual and customary, similar to the covenants on the Senior First Lien Notes due 2026 as described above. Adient incurred $10 million of debt issuance cost associated with this new debt in fiscal 2020. In January 2022, Adient commenced a cash tender offer for any and all of the Senior First Lien Notes due 2025.
As discussed in the On-Going Impact of COVID-19 section, the spread of COVID-19 and the measures taken to restrain the spread of the virus have had, and may continue to have, a material negative impact on Adient's financial results and liquidity, and such negative impact may continue well beyond the containment of such outbreak. Adient cannot assure that its assumptions used to estimate the liquidity requirements will be correct because it has never previously experienced such a widespread cessation of its operations. In addition, the magnitude, duration, speed and potential resurgence of the global pandemic is uncertain. Consequently, the impact on Adient's business, financial condition or longer-term financial or operational results is uncertain. Based on the actions it has taken and its assumptions regarding the impact of COVID-19, Adient believes that its current financial resources will be sufficient to fund its liquidity requirements for at least the next twelve months.
As previously noted, in connection with the YFAS Sale, as part of the 2021 Yanfeng Transaction, Adient received CNY ¥8,064 million ($1,210 million) for all of the issued and outstanding equity interest in YFAS held by Adient. A portion of these proceeds ((¥3,446 million ($519 million)) was paid to Adient upon the YFAS Sale Closing on September 30, 2021 and the remainder (¥4,618 million ($691 million)) was paid to Adient during the first quarter of fiscal 2022. Further, in conjunction with the closing of the Boxun Equity Purchase in January 2022 as part of the 2021 Yanfeng Transaction, Adient will pay Boxun approximately $200 million ($15 million of historical dividends paid in December 2021, $170 million paid in Jaunary 2022, and $15 million to be paid in the second quarter of fiscal 2022 after completion of the 2021 financial audit). Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.
Sources of Cash Flows

|  | Three Months Ended December 31,
(in millions) |  | 2021 |  | 2020
Cash provided (used) by operating activities |  | $ | (14) |  |  | $ | 231 |
Cash provided (used) by investing activities |  | 652 |  |  | (61) |
Cash provided (used) by financing activities |  | (79) |  |  | (68) |
Capital expenditures |  | (60) |  |  | (71) |

Operating Cash Flows: The decrease in cash flows from operating activities is primarily due to lower net income attributable to Adient, and overall unfavorable changes to working capital year-over-year resulting in part from higher accounts receivable balance.
Adient plc | Form 10-Q | 40

Investing Cash Flows: The increase in cash provided by investing activities is primarily attributable to the $651 million proceeds received related to the 2021 Yanfeng Transaction during the current quarter, $36 million in proceeds received from the sale of the assets in Turkey, the collection of $41 million of deferred proceeds from the sale of Adient's interest in YFAI as part of the 2020 Yanfeng Transaction and lower capital expenditures, partially offset by the $30 million settlement of the derivative contracts related to the cash proceeds of the 2021 Yanfeng Transaction. Refer to Note 3, “Acquisitions and Divestitures,” and Note 9, “Derivative Instruments and Hedging Activities,” of the notes to the consolidated financial statements for additional information.
Financing Cash Flows: The increase in cash used by financing activities is attributable to higher dividend payments to noncontrolling interest holders during the current quarter and higher levels of withholding taxes on share-based compensation awards.
Capital expenditures: Capital expenditures decreased year over year based on timing of program spend on product launches and continued tightening of controls around overall spending.
Working capital

(in millions) |  | December 31, 2021 |  | September 30, 2021
Current assets |  | $ | 5,091 |  |  | $ | 5,086 |
Current liabilities |  | 3,742 |  |  | 3,511 |
Working capital |  | $ | 1,349 |  |  | $ | 1,575 |

The decrease in working capital of $226 million is primarily attributable to the reclassification of the Boxun redeemable noncontrolling interest to other current liabilities at December 31, 2021, as well as higher accounts payable, partially offset by higher accounts receivable balance and lower restructuring reserves.
Restructuring Costs
During the first quarter of fiscal 2022, Adient committed to a restructuring plan ("2022 Plan") of $3 million that was offset by $6 million of prior year underspend. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA and Americas. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2022 restructuring plan will reduce annual operating costs by approximately $6 million, which is primarily the result of lower costs of sales and selling, general and administrative expenses due to reduced employee-related costs, of which approximately 40% will result in net savings. The restructuring actions are expected to be substantially completed within fiscal 2022.
During fiscal 2021, Adient committed to a restructuring plan ("2021 Plan") of $27 million that was offset by $16 million of prior year underspend. Of the restructuring costs recorded, $23 million related to the EMEA segment, $3 million related to the Americas segment, and $1 million related to the Asia segment. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2021 restructuring plan will reduce annual operating costs by approximately $16 million, which is primarily the result of lower costs of sales and selling, general and administrative expenses due to reduced employee-related costs, of which approximately 20%-30% will result in net savings. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions and lease contract terminations. The restructuring actions are expected to be substantially completed by fiscal 2023.
Adient's restructuring plans include workforce reductions of approximately 15,000 employees. Restructuring charges associated with employee severance and termination benefits are paid over the severance period granted to each employee or on a lump sum basis in accordance with individual severance agreements. As of December 31, 2021, approximately 14,000 of the employees have been separated from Adient pursuant to the restructuring plans. In addition, the restructuring plans included twenty-five plant closures. As of December 31, 2021, twenty of the twenty-five plants have been closed.
Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Because of the importance of new vehicle sales by major automotive manufacturers to operations, Adient is affected by the general business conditions in the automotive industry. Future adverse developments in the automotive industry, particularly related to or as a result of the COVID-19 pandemic, could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.
Adient plc | Form 10-Q | 41

Off-Balance Sheet Arrangements and Contractual Obligations
There have been no material changes to the off-balance sheet arrangements and contractual obligations disclosed in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021.
Effects of Inflation and Changing Prices
The effects of inflation have historically not been significant to Adient's results of operations. Generally, Adient has been able to implement operating efficiencies to sufficiently offset cost increases, which have been moderate. The automotive industry has recently experienced a period of sustained price increases for commodities such as steel and to a lesser extent petrochemicals, as well as higher freight costs, that may continue in the future as demand increases and supply may remain constrained which has resulted in, and may continue to result in, increased costs for Adient that may not be, or may only be partially, offset.
Critical Accounting Estimates and Policies
See "Critical Accounting Estimates and Policies" under the heading "Item 7" of Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021, for a discussion of critical accounting estimates and policies. There have been no material changes to Adient's critical accounting estimates and policies during the three months ended December 31, 2021.
New Accounting Pronouncements
See Note 1, "Basis of Presentation and Summary of Significant Accounting Policies," of the notes to consolidated financial statements for a discussion of new accounting pronouncements.
Adient plc | Form 10-Q | 42

Other Information
Not applicable

Item 3. | Quantitative and Qualitative Disclosures About Market Risk

As of December 31, 2021, Adient had not experienced any adverse changes in market risk exposures that materially affected the quantitative and qualitative disclosures presented in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021.

Item 4. | Controls and Procedures

Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, Adient's principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the "Exchange Act")), which are designed to provide reasonable assurance that we are able to record, process, summarize and report the information required to be disclosed in our reports under the Exchange Act within the time periods specified in SEC rules and forms. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to management, and made known to our principal executive officer and principal financial officer, on a timely basis to ensure that it is recorded, processed, summarized and reported within the time period specified in the SEC's rules and forms.
Changes in Internal Control over Financial Reporting
There were no changes in internal control over financial reporting during the three months ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Adient plc | Form 10-Q | 43

PART II - OTHER INFORMATION

Item 1. | Legal Proceedings |  |  |

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, product safety, environmental, safety and health, intellectual property, employment, commercial and contractual matters and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Adient accrues for potential liabilities in a manner consistent with accounting principles generally accepted in the United States, that is, when it is probable a liability has been incurred and the amount of the liability is reasonably estimable.
Information with respect to this item may be found in Note 17, "Commitments and Contingencies," of the notes to consolidated financial statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.
Additional information on Adient's commitments and contingencies can be found in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021.

Item 1A. | Risk Factors |  |  |

Adient has updated or supplemented the below risk factor to reflect recent developments and this should be read in combination with those previously reported in Adient’s Annual Report on Form 10-K for the fiscal year ended September 30, 2021. To the extent applicable, the following risk factor update supersedes the corresponding risk factor previously reported in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021.
COVID-19 vaccination mandates adopted by federal, state and local governments could have a material adverse impact on our business and results of operations.
While OSHA’s Emergency Temporary Standard has been withdrawn, state and local governments in which our business operates may implement or announce COVID-19 vaccination requirements applicable to certain of our employees. It is currently not possible to predict with certainty the impact these vaccination mandates, if implemented, will have on our business, especially on our workforce. Our implementation of these requirements may result in costs to us in the form of vaccinations or testing of employees. These requirements may also result in attrition in our workforce, including attrition of critically skilled labor, and difficulty securing future labor needs, which could have a material adverse effect on our business, financial condition, and results of operations.

Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds

(a) Unregistered Sale of Equity Securities
None.
(b) Use of Proceeds
Not applicable.
(c) Repurchase of Equity Securities
There has been no share repurchase activity during the three months ended December 31, 2021.

Item 3. | Defaults Upon Senior Securities |  |  |

Adient plc | Form 10-Q | 44

None.

Item 4. | Mine Safety Disclosures |  |  |

Not applicable.

Item 5. | Other Information |  |  |

None.

Adient plc | Form 10-Q | 45

Item 6. | Exhibit Index |  |  |

EXHIBIT INDEX

Exhibit No. |  | Exhibit Title
31.1 |  |  | Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 |  |  | Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 |  |  | Certification of Periodic Financial Report by the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS |  | XBRL Instance Document
101.SCH |  | XBRL Taxonomy Extension Schema Document
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document
101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document
104 |  |  | Cover Page Interactive Data File (embedded within the Inline XBRL document)

Adient plc | Form 10-Q | 46

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Adient plc
| By: | /s/ Douglas G. Del Grosso
|  | Douglas G. Del Grosso
|  | President and Chief Executive Officer and a Director
| Date: | February 4, 2022
| By: | /s/ Jeffrey M. Stafeil
|  | Jeffrey M. Stafeil
|  | Executive Vice President and Chief Financial Officer
| Date: | February 4, 2022

Adient plc | Form 10-Q | 47